Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1,800,000 Profiles
More than 3,500 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

José Gatell

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.8 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Living Beings

HIV-1

Procedures

Concepts & Ideas

Chemicals & Drugs

Geographic Areas

Spain

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Climent Núria; Martinez-Navio José M; Gil Cristina; Garcia Felipe; Rovira Cristina; Hurtado Carmen; Miralles Laia; Gatell José M; Gallart Teresa; Mallol Josefa; Lluis Carme; Franco Rafael
Adenosine deaminase enhances T-cell response elicited by dendritic cells loaded with inactivated HIV.
López Anna; van der Lubbe Nils; Sánchez-Palomino Sonsoles; Arnedo Mireia; Nomdedeu Meritxell; Castro Pedro; Guilà Meritxell; Maleno Maria J; García Felipe; Gallart Teresa; Gatell José M; Plana Montserrat
Phenotypic and functional characteristics of HIV-specific CD8 T cells and gag sequence variability after autologous dendritic cells based therapeutic vaccine.
Miró J M; García-de-la-Mària C; Armero Y; Soy D; Moreno A; del Río A; Almela M; Sarasa M; Mestres C A; Gatell J M; Jiménez de Anta M T; Marco F;
Addition of gentamicin or rifampin does not enhance the effectiveness of daptomycin in treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of José Gatell (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Climent Núria; Martinez-Navio José M; Gil Cristina; Garcia Felipe; Rovira Cristina; Hurtado Carmen; Miralles Laia; Gatell José M; Gallart Teresa; Mallol Josefa; Lluis Carme; Franco Rafael
Adenosine deaminase enhances T-cell response elicited by dendritic cells loaded with inactivated HIV.
Immunology and cell biology 2009;87(8):634-9.
2009: López Anna; van der Lubbe Nils; Sánchez-Palomino Sonsoles; Arnedo Mireia; Nomdedeu Meritxell; Castro Pedro; Guilà Meritxell; Maleno Maria J; García Felipe; Gallart Teresa; Gatell José M; Plana Montserrat
Phenotypic and functional characteristics of HIV-specific CD8 T cells and gag sequence variability after autologous dendritic cells based therapeutic vaccine.
Vaccine 2009;27(44):6166-78.
2009: Miró J M; García-de-la-Mària C; Armero Y; Soy D; Moreno A; del Río A; Almela M; Sarasa M; Mestres C A; Gatell J M; Jiménez de Anta M T; Marco F;
Addition of gentamicin or rifampin does not enhance the effectiveness of daptomycin in treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
Antimicrobial agents and chemotherapy 2009;53(10):4172-7.
2009: Martínez Esteban; Arranz José A; Podzamczer Daniel; Loncá Montserrat; Sanz José; Barragán Patricia; Ribera Esteban; Knobel Hernando; Roca Victor; Gutiérrez Félix; Blanco José L; Mallolas Josep; Llibre Josep M; Clotet Bonaventura; Dalmau David; Segura Ferran; Arribas José R; Cosín Jaime; Barrufet Pilar; Casas Esperanza; Ferrer Elena; Curran Adrià; González Alicia; Pich Judit; Cruceta Ana; Arnaiz Joan A; Miró José M; Gatell José M;
A simplification trial switching from nucleoside reverse transcriptase inhibitors to once-daily fixed-dose abacavir/lamivudine or tenofovir/emtricitabine in HIV-1-infected patients with virological suppression.
Journal of acquired immune deficiency syndromes (1999) 2009;51(3):290-7.
2009: Rodríguez-García Marta; Oliva Harold; Climent Núria; Escribese Maria M; García Felipe; Moran Thomas M; Gatell José M; Gallart Teresa
Impact of alpha-defensins1-3 on the maturation and differentiation of human monocyte-derived DCs. Concentration-dependent opposite dual effects.
Clinical immunology (Orlando, Fla.) 2009;131(3):374-84.
2009: Mallolas Josep; Podzamczer Daniel; Milinkovic Ana; Domingo Pere; Clotet Bonaventura; Ribera Esteve; Gutiérrez Félix; Knobel Hernando; Cosin Jaime; Ferrer Elena; Arranz José Alberto; Roca Victor; Vidal Francesc; Murillas Javier; Pich Judit; Pedrol Enric; Llibre Josep M; Dalmau David; García Isabel; Aranda Miquel; Cruceta Ana; Martínez Esteban; Blanco José L; Lazzari Elisa de; Gatell José M;
Efficacy and safety of switching from boosted lopinavir to boosted atazanavir in patients with virological suppression receiving a LPV/r-containing HAART: the ATAZIP study.
Journal of acquired immune deficiency syndromes (1999) 2009;51(1):29-36.
2009: Martínez Esteban; Larrousse María; Gatell José M
Cardiovascular disease and HIV infection: host, virus, or drugs?
Current opinion in infectious diseases 2009;22(1):28-34.
2008: Gatell José M; Zamora Laura
[Secondary effects associated with raltegravir]
Enfermedades infecciosas y microbiología clínica 2008;26 Suppl 12():34-9.
2008: Gatell José M
[Efficacy of raltegravir: from healthy volunteers to phase III trials]
Enfermedades infecciosas y microbiología clínica 2008;26 Suppl 12():29-33.
2008: Gatell José M
[Raltegravir: the first HIV integrase inhibitor. Introduction]
Enfermedades infecciosas y microbiología clínica 2008;26 Suppl 12():1-2.
2008: Martin M; Del Cacho E; Codina C; Tuset M; De Lazzari E; Mallolas J; Miró J-M; Gatell J M; Ribas J
Relationship between adherence level, type of the antiretroviral regimen, and plasma HIV type 1 RNA viral load: a prospective cohort study.
AIDS research and human retroviruses 2008;24(10):1263-8.
2008: Alvarez-Martínez Míriam J; Moreno Asunción; Miró José M; Valls Maria Eugenia; Rivas Paula V; de Lazzari Elisa; Sued Omar; Benito Natividad; Domingo Pere; Ribera Esteban; Santín Miguel; Sirera Guillermo; Segura Ferràn; Vidal Francesc; Rodríguez Francisco; Riera Melchor; Cordero Maria Elisa; Arribas José Ramón; Jiménez de Anta Maria Teresa; Gatell José M; Wilson Paul E; Meshnick Steven R;
Pneumocystis jirovecii pneumonia in Spanish HIV-infected patients in the combined antiretroviral therapy era: prevalence of dihydropteroate synthase mutations and prognostic factors of mortality.
Diagnostic microbiology and infectious disease 2008;62(1):34-43.
2008: Marco Francesc; de la Mària Cristina García; Armero Yolanda; Amat Eurídice; Soy Dolors; Moreno Asunción; del Río Ana; Almela Manel; Mestres Carlos A; Gatell José M; Jiménez de Anta María Teresa; Miró José M;
Daptomycin is effective in treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.
Antimicrobial agents and chemotherapy 2008;52(7):2538-43.
2008: Mocroft A; Kirk O; Aldins P; Chies A; Blaxhult A; Chentsova N; Vetter N; Dabis F; Gatell J; Lundgren J D;
Loss to follow-up in an international, multicentre observational study.
HIV medicine 2008;9(5):261-9.
2008: Martí Luis; Cervera Carlos; Filella Xavier; Marín José Luis; Almela Manel; Gatell José M; Moreno Asunción
[Inflammatory response in elderly patients with bacteremia]
Enfermedades infecciosas y microbiología clínica 2008;26(3):146-9.
2008: Jaén Angeles; Esteve Anna; Miró Josep M; Tural Cristina; Montoliu Alexandra; Ferrer Elena; Riera Melcior; Segura Ferran; Force Lluis; Sued Omar; Vilaró Josep; Garcia Isabel; Masabeu Angels; Altès Jordi; Coltet Bonaventura; Podzamczer Daniel; Murillas Javier; Navarro Gemma; Gatell Josep M; Casabona Jordi;
Determinants of HIV progression and assessment of the optimal time to initiate highly active antiretroviral therapy: PISCIS Cohort (Spain).
Journal of acquired immune deficiency syndromes (1999) 2008;47(2):212-20.
2008: Mallolas Josep; Pich Judith; Peñaranda María; Domingo Pere; Knobel Hernando; Pedrol Enric; Gutiérrez Félix; Barrufet Pilar; Peraire Joaquin; Asenjo Miguel A; Vidal Francesc; Gatell Josep M
Induction therapy with trizivir plus efavirenz or lopinavir/ritonavir followed by trizivir alone in naive HIV-1-infected adults.
AIDS (London, England) 2008;22(3):377-84.
2007: Larrousse Maria; Laguno Montserrat; Segarra Marta; De Lazzari Elisa; Martinez Esteban; Blanco José Luis; León Agathe; Deulofeu Ramón; Miquel Rosa; Milinkovic Ana; Lonca Montserrat; Miró José María; Biglia Alejandra; Murillas Javier; Gatell José María; Mallolas Josep
Noninvasive diagnosis of hepatic fibrosis in HIV/HCV-coinfected patients.
Journal of acquired immune deficiency syndromes (1999) 2007;46(3):304-11.
2007: Garrido Marta; Mozos Anna; Martínez Antonio; García Felipe; Serafín Anna; Morente Vanesa; Caballero Miguel; Gil Cristina; Fumero Emilio; Miró Jose M; Climent Nuria; Gatell Jose M; Alos Llucia
HIV-1 upregulates intercellular adhesion molecule-1 gene expression in lymphoid tissue of patients with chronic HIV-1 infection.
Journal of acquired immune deficiency syndromes (1999) 2007;46(3):268-74.
2007: Rodríguez-García Marta; Oliva Harold; Climent Núria; García Felipe; Gatell José M; Gallart Teresa
Human immature monocyte-derived dendritic cells produce and secrete alpha-defensins 1-3.
Journal of leukocyte biology 2007;82(5):1143-6.
2007: Suy Anna; Castro Pedro; Nomdedeu Meritxell; García Felipe; López Anna; Fumero Emilio; Gallart Teresa; Lopalco Lucia; Coll Oriol; Gatell José M; Plana Montserrat
Immunological profile of heterosexual highly HIV-exposed uninfected individuals: predominant role of CD4 and CD8 T-cell activation.
The Journal of infectious diseases 2007;196(8):1191-201.
2007: Ceccherini-Silberstein Francesca; Cozzi-Lepri Alessandro; Ruiz Lidia; Mocroft Amanda; Phillips Andrew N; Olsen Christian Holkmann; Gatell Jose M; Gunthard Huldrych F; Reiss Peter; Perno Carlo Federico; Clotet Bonaventura; Lundgren Jens D;
Impact of HIV-1 reverse transcriptase polymorphism F214L on virological response to thymidine analogue-based regimens in antiretroviral therapy (ART)-naive and ART-experienced patients.
The Journal of infectious diseases 2007;196(8):1180-90.
2007: Mallolas J; Blanco J L; Pich J; Arnaiz J A; Peña J M; Dalmau D; de Lazzari E; Ochoa A; Vidal F; Ribas M A; Segura F; Pedrol E; Flores J; Cruceta A; Varea S; Miró J M; Martínez E; Gatell J M
A randomized trial comparing the efficacy and tolerability of two HAART strategies at two years in antiretroviral naive patients.
Revista clínica española 2007;207(9):427-32.
2007: Ferrer Elena; Niubo Jordi; Crespo Manel; Gatell Josep Maria; Sanz Jose; Veloso Sergio; Llibre Josep Maria; Barrufet Pilar; Sanchez Pochita; Podzamczer Daniel;
Genotypic resistance in HIV-infected naive patients receiving abacavir plus lamivudine and efavirenz.
Journal of acquired immune deficiency syndromes (1999) 2007;46(2):253-5.
2007: Ramos-Casals M; Forns X; Brito-Zerón P; Vargas A; Ruiz M; Laguno M; Yagüe J; Sánchez-Tapias J M; Gatell J M; Font J
Cryoglobulinaemia associated with hepatitis C virus: influence of HCV genotypes, HCV-RNA viraemia and HIV coinfection.
Journal of viral hepatitis 2007;14(10):736-42.
2007: León A; Martinez E; Sarasa M; López Y; Mallolas J; De Lazzari E; Laguno M; Milincovic A; Blanco J L; Larrousse M; Lonca M; Gatell J M
Impact of steady-state lopinavir plasma levels on plasma lipids and body composition after 24 weeks of lopinavir/ritonavir-containing therapy free of thymidine analogues.
The Journal of antimicrobial chemotherapy 2007;60(4):824-30.
2007: Peraire Joaquim; Miró Oscar; Saumoy Maria; Domingo Pere; Pedrol Enric; Villarroya Francesc; Martínez Esteban; López-Dupla Miguel; Garrabou Glória; Sambeat M Antònia; Deig Elisabet; Villarroya Joan; Chacón Matilde R; López Sònia; Fontanet Angels; Holmstrom Maija; Giralt Marta; Gatell Josep M; Vidal Francesc
HIV-1-infected long-term non-progressors have milder mitochondrial impairment and lower mitochondrially-driven apoptosis in peripheral blood mononuclear cells than typical progressors.
Current HIV research 2007;5(5):467-73.
2007: Bruguera Miquel; Torres Miquel; Campins Magda; Bayas José M; Segura Andreu; Barrio José Luis; Esteban Rafael; Gatell Josep M; Martínez Magda; Monés Joan; Plans Angel; Planas Ramon; Serra Consol; Tural Cristina; Villalbí Joan Ramon
[Risk of transmission of HIV or hepatitis B or C viruses from an infected physician. Preventive measures]
Medicina clínica 2007;129(8):309-13.
2007: Im Eung-Jun; Saubi Narcís; Virgili Goretti; Sander Clare; Teoh Denise; Gatell Jose M; McShane Helen; Joseph Joan; Hanke Tomás
Vaccine platform for prevention of tuberculosis and mother-to-child transmission of human immunodeficiency virus type 1 through breastfeeding.
Journal of virology 2007;81(17):9408-18.
2007: Horcajada Juan Pablo; García Laura; Benito Natividad; Cervera Carlos; Sala Marta; Olivera Angels; Soriano Alex; Robau Marga; Gatell José M; Miró José M
[Specialized home care for infectious disease. Experience from 1995 to 2002]
Enfermedades infecciosas y microbiología clínica 2007;25(7):429-36.
2007: Martínez Esteban; Gatell José M
Considerations on the effectiveness of nevirapine in protease inhibitor-based regimen simplification.
AIDS (London, England) 2007;21(13):1829-30.
2007: Mocroft A; Phillips A N; Gatell J; Ledergerber B; Fisher M; Clumeck N; Losso M; Lazzarin A; Fatkenheuer G; Lundgren J D;
Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study.
Lancet 2007;370(9585):407-13.
2007: Guerra Susana; Nájera José Luis; González José Manuel; López-Fernández Luis A; Climent Nuria; Gatell José M; Gallart Teresa; Esteban Mariano
Distinct gene expression profiling after infection of immature human monocyte-derived dendritic cells by the attenuated poxvirus vectors MVA and NYVAC.
Journal of virology 2007;81(16):8707-21.
2007: Castro Pedro; Laguno Montserrat; Nomdedeu Meritxell; López Anna; Plana Montserrat; Fumero Emilio; Gallart Teresa; Mallolas Josep; Gatell José M; García Felipe
Clinicoimmunological progression and response to treatment of long-term nonprogressor HIV-hepatitis C virus-coinfected patients.
AIDS research and human retroviruses 2007;23(7):863-7.
2007: Naranjo-Gómez Mar; Oliva Harold; Climent Nuria; Fernández Marco A; Ruiz-Riol Marta; Bofill Margarita; Gatell José M; Gallart Teresa; Pujol-Borrell Ricardo; Borràs Francesc E
Expression and function of the IL-2 receptor in activated human plasmacytoid dendritic cells.
European journal of immunology 2007;37(7):1764-72.
2007: Miró José M; García-de-la-Mària Cristina; Armero Yolanda; de-Lazzari Elisa; Soy Dolors; Moreno Asunción; del Rio Ana; Almela Manel; Mestres Carlos A; Gatell José M; Jiménez-de-Anta María-Teresa; Marco Francesc;
Efficacy of telavancin in the treatment of experimental endocarditis due to glycopeptide-intermediate Staphylococcus aureus.
Antimicrobial agents and chemotherapy 2007;51(7):2373-7.
2007: Martín María Teresa; del Cacho Elena; López Ester; Codina Carles; Tuset Montserrat; de Lazzari Elisa; Miró Josep M; Gatell Josep M; Ribas Josep
[Adverse side effects of antiretroviral therapy: relationship between patients' perception and adherence]
Medicina clínica 2007;129(4):127-33.
2007: Gatell Jose; Salmon-Ceron Dominique; Lazzarin Adriano; Van Wijngaerden Eric; Antunes Francisco; Leen Clifford; Horban Andrzej; Wirtz Victoria; Odeshoo Linda; Van den Dungen Monique; Gruber Claudia; Ledesma Emilio;
Efficacy and safety of atazanavir-based highly active antiretroviral therapy in patients with virologic suppression switched from a stable, boosted or unboosted protease inhibitor treatment regimen: the SWAN Study (AI424-097) 48-week results.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;44(11):1484-92.
2007: Mocroft Amanda; Kirk Ole; Gatell Jose; Reiss Peter; Gargalianos Panagiotis; Zilmer Kai; Beniowski Marek; Viard Jean-Paul; Staszewski Schlomo; Lundgren Jens D
Chronic renal failure among HIV-1-infected patients.
AIDS (London, England) 2007;21(9):1119-27.
2007: Martínez E; Milinkovic A; Buira E; de Lazzari E; León A; Larrousse M; Loncá M; Laguno M; Blanco J L; Mallolas J; García F; Miró J M; Gatell J M
Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area.
HIV medicine 2007;8(4):251-8.
2007: Mallolas J; Blanco Jl; Labarga P; Vergara A; Ocampo A; Sarasa M; Arnedo M; López-Púa Y; García J; Juega J; Guelar A; Terrón A; Dalmau D; García I; Zárraga M; Martínez E; Carné X; Pumarola T; Escayola R; Gatell Jm
Inhibitory quotient as a prognostic factor of response to a salvage antiretroviral therapy containing ritonavir-boosted saquinavir. The CIVSA Study.
HIV medicine 2007;8(4):226-33.
2007: Grinsztejn Beatriz; Nguyen Bach-Yen; Katlama Christine; Gatell Jose M; Lazzarin Adriano; Vittecoq Daniel; Gonzalez Charles J; Chen Joshua; Harvey Charlotte M; Isaacs Robin D;
Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial.
Lancet 2007;369(9569):1261-9.
2007: Peraire Joaquim; Vidal Francesc; Plana Montserrat; Domingo Pere; Coll Blai; Viladés Consuelo; Garcia Felipe; Veloso Sergi; Gatell Josep M; Broch Montserrat
Polymorphisms in the 3' untranslated region of the fractalkine (CX3CL1) gene and the risk of HIV-1 infection and disease progression.
AIDS (London, England) 2007;21(7):891-3.
2007: Hill Andrew; Ruxrungtham Kiat; Hanvanich Mattana; Katlama Christine; Wolf Eva; Soriano Vincent; Milinkovic Ana; Gatell Jose; Ribera Esteban
Systematic review of clinical trials evaluating low doses of stavudine as part of antiretroviral treatment.
Expert opinion on pharmacotherapy 2007;8(5):679-88.
2007: Rousaud Araceli; Blanch Jordi; Hautzinger Martin; De Lazzari Elisa; Peri Josep Maria; Puig Olga; Martinez Esteban; Masana Guillem; De Pablo Joan; Gatell Josep Maria
Improvement of psychosocial adjustment to HIV-1 infection through a cognitive-behavioral oriented group psychotherapy program: a pilot study.
AIDS patient care and STDs 2007;21(3):212-22.
2007: Mallolas J; Sarasa M; Nomdedeu M; Soriano A; López-Púa Y; Blanco J L; Martínez E; Gatell J M
Pharmacokinetic interaction between rifampicin and ritonavir-boosted atazanavir in HIV-infected patients.
HIV medicine 2007;8(2):131-4.
2007: Libois Agnès; De Wit Stéphane; Poll Bénédicte; Garcia Felipe; Florence Eric; Del Rio Ana; Sanchez Paquita; Negredo Eugenia; Vandenbruaene Marc; Gatell José M; Clumeck Nathan
HIV and syphilis: when to perform a lumbar puncture.
Sexually transmitted diseases 2007;34(3):141-4.
2007: Katlama Christine; Esposito Roberto; Gatell Jose M; Goffard Jean-Christophe; Grinsztejn Beatriz; Pozniak Anton; Rockstroh Jurgen; Stoehr Albrecht; Vetter Norbert; Yeni Patrick; Parys Wim; Vangeneugden Tony;
Efficacy and safety of TMC114/ritonavir in treatment-experienced HIV patients: 24-week results of POWER 1.
AIDS (London, England) 2007;21(4):395-402.
2007: Laguno Montserrat; Larrousse María; Murillas Javier; Blanco José Luis; León Agathe; Milinkovic Ana; Loncá Montserrat; Martinez Esteban; Sánchez-Tapias José Maria; de Lazzari Elisa; Gatell Josep Maria; Costa Josep; Mallolas Josep
Predictive value of early virologic response in HIV/hepatitis C virus-coinfected patients treated with an interferon-based regimen plus ribavirin.
Journal of acquired immune deficiency syndromes (1999) 2007;44(2):174-8.
2007: Podzamczer Daniel; Ferrer Elena; Sanchez Pochita; Gatell José M; Crespo Manel; Fisac Cesar; Lonca Montse; Sanz Jose; Niubo Jordi; Veloso Sergio; Llibre Josep M; Barrufet Pilar; Ribas María A; Merino Esperanza; Ribera Esteban; Martínez-Lacasa Javier; Alonso Carlos; Aranda Miquel; Pulido Federico; Berenguer Juan; Delegido Antonio; Pedreira Juan D; Lérida Ana; Rubio Rafael; del Río Luis;
Less lipoatrophy and better lipid profile with abacavir as compared to stavudine: 96-week results of a randomized study.
Journal of acquired immune deficiency syndromes (1999) 2007;44(2):139-47.
2007: Viladés Consuelo; Broch Montserrat; Plana Montserrat; Domingo Pere; Alonso-Villaverde Carlos; Pedrol Enric; Knobel Hernando; Dalmau David; Peraire Joaquim; Gutiérrez Cristina; López Anna; Sambeat Maria Antònia; Olona Montserrat; Garcia Felipe; Richart Cristóbal; Gatell Josep Maria; Vidal Francesc;
Effect of genetic variants of CCR2 and CCL2 on the natural history of HIV-1 infection: CCL2-2518GG is overrepresented in a cohort of Spanish HIV-1-infected subjects.
Journal of acquired immune deficiency syndromes (1999) 2007;44(2):132-8.
2007: Martínez Esteban; Arnaiz Juan A; Podzamczer Daniel; Dalmau David; Ribera Esteban; Domingo Pere; Knobel Hernando; Leyes Maria; Pedrol Enric; Force Luís; de Lazzari Elisa; Gatell José M
Three-year follow-up of protease inhibitor-based regimen simplification in HIV-infected patients.
AIDS (London, England) 2007;21(3):367-9.
2007: Milinkovic Ana; Martinez Esteban; López Sonia; de Lazzari Elisa; Miró Oscar; Vidal Sergi; Blanco José L; Garrabou Gloria; Laguno Montserrat; Arnaiz Joan A; Leon Agathe; Larrousse Maria; Lonca Montserrat; Mallolas Josep; Gatell José M
The impact of reducing stavudine dose versus switching to tenofovir on plasma lipids, body composition and mitochondrial function in HIV-infected patients.
Antiviral therapy 2007;12(3):407-15.
2007: Mocroft Amanda; Staszewski Schlomo; Weber Rainer; Gatell José; Rockstroh Jurgen; Gasiorowski Jacek; Panos George; Monforte Antonella d'Arminio; Rakhmanova Aza; Phillips Andrew N; Lundgren Jens D;
Risk of discontinuation of nevirapine due to toxicities in antiretroviral-naive and -experienced HIV-infected patients with high and low CD4+ T-cell counts.
Antiviral therapy 2007;12(3):325-33.
2007: Larder Brendan; Wang Dechao; Revell Andrew; Montaner Julio; Harrigan Richard; De Wolf Frank; Lange Joep; Wegner Scott; Ruiz Lidia; Pérez-Elías Maria Jésus; Emery Sean; Gatell Jose; Monforte Antonella D'Arminio; Torti Carlo; Zazzi Maurizio; Lane Clifford
The development of artificial neural networks to predict virological response to combination HIV therapy.
Antiviral therapy 2007;12(1):15-24.
2006: Joseph Joan; Saubi Narcís; Pezzat Elías; Gatell Josep Maria
Progress towards an HIV vaccine based on recombinant bacillus Calmette-Guérin: failures and challenges.
Expert review of vaccines 2006;5(6):827-38.
2006: Naranjo-Gómez Mar; Climent Nuria; Cos Joan; Oliva Harold; Bofill Margarita; Gatell José M; Gallart Teresa; Pujol-Borrell Ricardo; Borràs Francesc E
Tacrolimus treatment of plasmacytoid dendritic cells inhibits dinucleotide (CpG-)-induced tumour necrosis factor-alpha secretion.
Immunology 2006;119(4):488-98.
2006: Pacheco Rodrigo; Oliva Harold; Martinez-Navío José M; Climent Núria; Ciruela Francisco; Gatell José M; Gallart Teresa; Mallol Josefa; Lluis Carmen; Franco Rafael
Glutamate released by dendritic cells as a novel modulator of T cell activation.
Journal of immunology (Baltimore, Md. : 1950) 2006;177(10):6695-704.
2006: Alvarez-Martínez Míriam J; Miró José M; Valls Maria Eugenia; Moreno Asunción; Rivas Paula V; Solé Manel; Benito Natividad; Domingo Pere; Muñoz Carmen; Rivera Esteban; Zar Heather J; Wissmann Gustavo; Diehl Ada R S; Prolla João C; de Anta Maria Teresa Jiménez; Gatell José M; Wilson Paul E; Meshnick Steven R;
Sensitivity and specificity of nested and real-time PCR for the detection of Pneumocystis jiroveci in clinical specimens.
Diagnostic microbiology and infectious disease 2006;56(2):153-60.
2006: Blanco Jose Luis; Biglia Alejandra; De Lazzari Elisa; Mallolas Josep; Martinez Esteban; Pumarola Tomás; Larrousse María; Milinkovic Ana; León Agathe; Lonca Montserrat; Laguno Montserrat; Gatell Josep María
Antiretroviral activity of didanosine in patients with different clusters of reverse transcriptase mutations.
AIDS (London, England) 2006;20(14):1891-2.
2006: Caceres Cesar; Gomez Enrique J; Garcia Felipe; Gatell Jose M; del Pozo Francisco
An integral care telemedicine system for HIV/AIDS patients.
International journal of medical informatics 2006;75(9):638-42.
2006: Hammer Scott M; Saag Michael S; Schechter Mauro; Montaner Julio S G; Schooley Robert T; Jacobsen Donna M; Thompson Melanie A; Carpenter Charles C J; Fischl Margaret A; Gazzard Brian G; Gatell Jose M; Hirsch Martin S; Katzenstein David A; Richman Douglas D; Vella Stefano; Yeni Patrick G; Volberding Paul A;
Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society--USA panel.
Topics in HIV medicine : a publication of the International AIDS Society, USA 2006;14(3):827-43.
2006: Mallolas Josep; Gatell Josep M; Bruguera Miguel
Transmission of HIV-1 from an obstetrician to a patient during a caesarean section.
AIDS (London, England) 2006;20(13):1785.
2006: Hammer Scott M; Saag Michael S; Schechter Mauro; Montaner Julio S G; Schooley Robert T; Jacobsen Donna M; Thompson Melanie A; Carpenter Charles C J; Fischl Margaret A; Gazzard Brian G; Gatell Jose M; Hirsch Martin S; Katzenstein David A; Richman Douglas D; Vella Stefano; Yeni Patrick G; Volberding Paul A;
Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel.
JAMA : the journal of the American Medical Association 2006;296(7):827-43.
2006: Libois Agnès; López Anna; Garcia Felipe; Castro Pedro; Maleno María J; García Ana; Climent Nuria; Arnedo Mireia; Gallart Teresa; Gatell José M; Plana Montserrat
Dynamics of T cells subsets and lymphoproliferative responses during structured treatment interruption cycles and after definitive interruption of HAART in early chronic HIV type-1-infected patients.
AIDS research and human retroviruses 2006;22(7):657-66.
2006: Bannister Wendy P; Kirk Ole; Gatell Jose M; Knysz Brygida; Viard Jean-Paul; Mens Helene; Monforte Antonella D'Arminio; Phillips Andrew N; Mocroft Amanda; Lundgren Jens D;
Regional changes over time in initial virologic response rates to combination antiretroviral therapy across Europe.
Journal of acquired immune deficiency syndromes (1999) 2006;42(2):229-37.
2006: Lifson Alan R; Rhame Frank S; Belloso Waldo H; Dragsted Ulrik B; El-Sadr Wafaa M; Gatell Jose M; Hoy Jennifer F; Krum Eric A; Nelson Ray; Pedersen Court; Pett Sarah L; Davey Richard T
Reporting and evaluation of HIV-related clinical endpoints in two multicenter international clinical trials.
HIV clinical trials 2006;7(3):125-41.
2006: Sierra Josep M; Sánchez Francesca; Castro Pedro; Salvadó Margarita; de la Red Gloria; Libois Agnes; Almela Manuel; March Francesca; Español Montserrat; Sambeat Maria Antonia; Romeu Joan; Brugal Maria Teresa; García de Olalla Patricia; Gatell Jose Maria; Vila Jordi; García Felipe; López Colomés Jose Luís; Caylà Joan A; Coll Pere
Group A streptococcal infections in injection drug users in Barcelona, Spain: epidemiologic, clinical, and microbiologic analysis of 3 clusters of cases from 2000 to 2003.
Medicine 2006;85(3):139-46.
2006: Blanco J L; Biglia A; Martinez E; Sánchez M; de Lazzari E; Leon A; Milinkovic A; Larrousse M; Lonca M; Laguno M; Mallolas J; Gatell J M
Intrathoracic fat in HIV-infected patients.
HIV medicine 2006;7(4):213-7.
2006: Sued Omar; Miró José M; Alquezar Aitor; Claramonte Xavier; García Felipe; Plana Montserrat; Arnedo Mireia; de Lazzari Elisa; Gil Cristina; Manzardo Christian; Blanco José L; Martínez Esteban; Mallolas Josep; Joseph Joan; Pumarola Tomás; Gallart Teresa; Gatell José M
Primary human immunodeficiency virus type 1 infection: clinical, virological and immunological characteristics of 75 patients (1997-2003).
Enfermedades infecciosas y microbiología clínica 2006;24(4):238-44.
2006: Gold J; Batterham M J; Rekers H; Harms M K; Geurts T B P; Helmyr P M E; Silva de Mendonça J; Falleiros Carvalho L H; Panos G; Pinchera A; Aiuti F; Lee C; Horban A; Gatell J; Phanuphak P; Prasithsirikul W; Gazzard B; Bloch M; Danner S A;
Effects of nandrolone decanoate compared with placebo or testosterone on HIV-associated wasting.
HIV medicine 2006;7(3):146-55.
2006: Lampe Fiona C; Gatell Jose M; Staszewski Schlomo; Johnson Margaret A; Pradier Christian; Gill M John; de Lazzari Elisa; Dauer Brenda; Youle Mike; Fontas Eric; Krentz Hartmut B; Phillips Andrew N
Changes over time in risk of initial virological failure of combination antiretroviral therapy: a multicohort analysis, 1996 to 2002.
Archives of internal medicine 2006;166(5):521-8.
2006: Gratacòs Laura; Tuset Montse; Codina Carles; Miró José M; Mallolas Josep; Miserachs Núria; Martín-Conde Maria Teresa; del Cacho Elena; Lazzari Elisa de; Ribas Josep; Gatell Josep M
[Antiretroviral therapy of HIV infection: duration and reasons for changing the first therapeutic regimen in 518 patients]
Medicina clínica 2006;126(7):241-5.
2006: Martínez Esteban; Milinkovic Ana; Bianchi Luis; Gatell José M
Considerations about the value of sonography for the measurement of regional body fat.
AIDS (London, England) 2006;20(3):465-6.
2006: Garrabou Glòria; Sanjurjo Eduard; Miró Oscar; Martínez Esteban; Infante Ana B; López Sònia; Cardellach Francesc; Gatell Josep M; Casademont Jordi
Noninvasive diagnosis of mitochondrial dysfunction in HAART-related hyperlactatemia.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;42(4):584-5.
2006: Berenguer Juan; Pérez-Elías María Jesús; Bellón José María; Knobel Hernando; Rivas-González Pablo; Gatell José María; Miguélez Máximo; Hernández-Quero José; Flores Juan; Soriano Vicente; Santos Ignacio; Podzamczer Daniel; Sala Monserrat; Camba Manuel; Resino Salvador;
Effectiveness and safety of abacavir, lamivudine, and zidovudine in antiretroviral therapy-naive HIV-infected patients: results from a large multicenter observational cohort.
Journal of acquired immune deficiency syndromes (1999) 2006;41(2):154-9.
2006: Mallolas Josep; Arnedo Mireia; Pumarola Tomás; Erice Alejo; Blanco José L; Martínez Esteban; Gatell Josep M
Transmission of HIV-1 from an obstetrician to a patient during a caesarean section.
AIDS (London, England) 2006;20(2):285-7.
2006: Coll Oriol; Suy Anna; Figueras Francesc; Vernaeve Valérie; Martínez Esteban; Mataró Daniel; Durban Mercè; Lonca Montserrat; Vidal Ricard; Gatell José María
Decreased pregnancy rate after in-vitro fertilization in HIV-infected women receiving HAART.
AIDS (London, England) 2006;20(1):121-3.
2006: Suy Anna; Martínez Esteban; Coll Oriol; Lonca Montserrat; Palacio Montserrat; de Lazzari Elisa; Larrousse María; Milinkovic Ana; Hernández Sandra; Blanco José L; Mallolas Josep; León Agathe; Vanrell Juan A; Gatell José M
Increased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy.
AIDS (London, England) 2006;20(1):59-66.
2005: Mocroft Amanda; Soriano Vincent; Rockstroh Jurgen; Reiss Peter; Kirk Ole; de Wit Stephane; Gatell Jose; Clotet Bonaventura; Phillips Andrew N; Lundgren Jens D;
Is there evidence for an increase in the death rate from liver-related disease in patients with HIV?
AIDS (London, England) 2005;19(18):2117-25.
2005: Ribera Esteban; Azuaje Carlos; Lopez Rosa M; Domingo Pere; Soriano Alex; Pou Leonor; Sánchez Paquita; Mallolas Josep; Sambea Maria Antonia; Falco Vicenç; Ocaña Imma; Lopez-Colomes Josep Lluis; Gatell Josep M; Pahissa Albert
Once-daily regimen of saquinavir, ritonavir, didanosine, and lamivudine in HIV-infected patients with standard tuberculosis therapy (TBQD Study).
Journal of acquired immune deficiency syndromes (1999) 2005;40(3):317-23.
2005: Soriano Alex; Lozano Francisco; Oliva Harold; García Felipe; Nomdedéu Meritxell; De Lazzari Elisa; Rodríguez Carmen; Barrasa Alicia; Lorenzo José I; Del Romero Jorge; Plana Montserrat; Miró José M; Gatell José M; Vives Jordi; Gallart Teresa
Polymorphisms in the interleukin-4 receptor alpha chain gene influence susceptibility to HIV-1 infection and its progression to AIDS.
Immunogenetics 2005;57(9):644-54.
2005: León Agathe; Mallolas Josep; Martinez Esteban; De Lazzari Elisa; Pumarola Tomás; Larrousse María; Milincovic Ana; Lonca Montserrat; Blanco Jose Luis; Laguno Montserrat; Biglia Alejandra; Gatell Josep María
High rate of virological failure in maintenance antiretroviral therapy with didanosine and tenofovir.
AIDS (London, England) 2005;19(15):1695-7.
2005: Arnedo-Valero M; Garcia F; Gil C; Guila T; Fumero E; Castro P; Blanco J L; Miró J M; Pumarola T; Gatell J M
Risk of selecting de novo drug-resistance mutations during structured treatment interruptions in patients with chronic HIV infection.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;41(6):883-90.
2005: Bäuerle Jochen; Miquel Rosa; Laguno Montse; Mallolas Josep; Murillas Javier; Gatell José M; Walker Ulrich A
Hepatic steatosis with stavudine in HIV/hepatitis C virus co-infection.
AIDS (London, England) 2005;19(13):1441-2.
2005: Ochoa de Echagüen Anna; Arnedo Mireia; Xercavins Mariona; Martinez Esteban; Rosón Beatriz; Ribera Esteve; Domingo Pere; González Alicia; Riera Melcior; Llibre Josep Maria; Gatell Josep Maria; Dalmau David;
Genotypic and phenotypic resistance patterns at virological failure in a simplification trial with nevirapine, efavirenz or abacavir.
AIDS (London, England) 2005;19(13):1385-91.
2005: Miró Oscar; López Sònia; Fernández-Solà Joaquim; Garrabou Glòria; Pedrol Enric; Badia Eva; Martínez Esteban; Cardellach Francesc; Gatell Josep M; Casademont Jordi
Short communication: HIV infection, antiretrovirals, and apoptosis: studies on skeletal muscle.
AIDS research and human retroviruses 2005;21(8):702-5.
2005: Pacheco R; Martinez-Navio J M; Lejeune M; Climent N; Oliva H; Gatell J M; Gallart T; Mallol J; Lluis C; Franco R
CD26, adenosine deaminase, and adenosine receptors mediate costimulatory signals in the immunological synapse.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(27):9583-8.
2005: Fisac Cesar; Fumero Emilio; Crespo Manuel; Roson Beatriz; Ferrer Elena; Virgili Nuria; Ribera Esteban; Gatell Jose Maria; Podzamczer Daniel
Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapine.
AIDS (London, England) 2005;19(9):917-25.
2005: Blanco José L; Biglia M Alejandra; Arnedo Mireia; Martínez Esteban; Mallolas Josep; Milinkovic Ana; Laguno Montserrat; Larrousse Maria; Leon Agathe; Lonca Montserrat; García Felipe; Miró José M; Pumarola Tomás; Gatell José M
Evolution of resistance mutations pattern in HIV-1-infected patients during intensification therapy with a boosted protease inhibitor.
AIDS (London, England) 2005;19(8):829-31.
2005: García Felipe; Lejeune Merylene; Climent Nuria; Gil Cristina; Alcamí José; Morente Vanessa; Alós Llucia; Ruiz Alba; Setoain Javier; Fumero Emilio; Castro Pedro; López Anna; Cruceta Anna; Piera Carlos; Florence Eric; Pereira Arturo; Libois Agnes; González Nuria; Guilá Meritxell; Caballero Miguel; Lomeña Francisco; Joseph Joan; Miró José M; Pumarola Tomás; Plana Montserrat; Gatell José M; Gallart Teresa
Therapeutic immunization with dendritic cells loaded with heat-inactivated autologous HIV-1 in patients with chronic HIV-1 infection.
The Journal of infectious diseases 2005;191(10):1680-5.
2005: Jaén Angeles; Casabona Jordi; Esteve Anna; Miró Jose M; Tural Cristina; Ferrer Elena; Riera Melchor; Segura Ferran; Force Lluís; Sued Omar; Vilaró Josep; Masabeu Angels; García Isabel; Dorca Esther; Altès Jordi; Navarro Gemma; Podzamczer Daniel; Villalonga Concepción; Clotet Bonaventura; Gatell Josep M;
[Clinical-epidemiological characteristics and antiretroviral treatment trends in a cohort of HIV infected patients. The PISCIS Project]
Medicina clínica 2005;124(14):525-31.
2005: Bäuerle J; Laguno M; Mauss S; Mallolas J; Murillas J; Miquel R; Schmutz G; Setzer B; Gatell J M; Walker U A
Mitochondrial DNA depletion in liver tissue of patients infected with hepatitis C virus: contributing effect of HIV infection?
HIV medicine 2005;6(2):135-9.
2005: Antón Esperança; Sala Montserrat; Mallolas Josep; Navarro Gemma; Cervantes Manuel; Gatell Josep M; Segura Ferran
[Clinical and epidemiological study of a series of HIV-infected patients over 50 years old]
Enfermedades infecciosas y microbiología clínica 2005;23(3):145-8.
2005: Olsen Christian Holkmann; Gatell Jose; Ledergerber Bruno; Katlama Christine; Friis-Møller Nina; Weber Jonathan; Horban Andrzéj; Staszewski Schlomo; Lundgren Jens D; Phillips Andrew N;
Risk of AIDS and death at given HIV-RNA and CD4 cell count, in relation to specific antiretroviral drugs in the regimen.
AIDS (London, England) 2005;19(3):319-30.
2005: Laguno Montse; Sánchez-Tapias José María; Murillas Javier; Forns Xavier; Blanco José L; Martínez Esteban; Larrousse María; León Agathe; Loncá Montse; Milinkovic Ana; Miró José M; García Felipe; Gatell José María; Mallolas Josep
[Advances in the diagnosis and treatment of hepatitis C virus infection in patients with and without HIV infection]
Enfermedades infecciosas y microbiología clínica 2005;23(1):32-40.
2005: León Agathe; Martinez Esteban; Mallolas Josep; Laguno Montserrat; Blanco Jose Luis; Pumarola Tomás; Gatell Josep María
Early virological failure in treatment-naive HIV-infected adults receiving didanosine and tenofovir plus efavirenz or nevirapine.
AIDS (London, England) 2005;19(2):213-5.
2005: Mauss Stefan; Milinkovic Ana; Hoffmann Christian; Holm Stefanie; Berger Florian; Martínez Esteban; Kuhlmann Birger; Gatell José; Schmutz Guenther
Low rate of treatment failure on antiretroviral therapy with tenofovir, lamivudine and zidovudine.
AIDS (London, England) 2005;19(1):101-2.
2005: Alòs Llúcia; Navarrete Pilar; Morente Vanesa; Garcia Felipe; Garrido Marta; Plana Montse; Mozos Anna; López Anna; Gil Cristina; Pumarola Tomás; Caballero Miguel; Blanch Jose L; Fumero Emilio; Miró José M; Gallart Teresa; Gatell José M; Campo Elias
Immunoarchitecture of lymphoid tissue in HIV-infection during antiretroviral therapy correlates with viral persistence.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2005;18(1):127-36.
2005: Miró Oscar; Villarroya Joan; Garrabou Glòria; López Sònia; Rodríguez de la Concepción Marisa; Pedrol Enric; Martínez Esteban; Giralt Marta; Gatell Josep M; Cardellach Francesc; Casademont Jordi; Villarroya Francesc
In vivo effects of highly active antiretroviral therapies containing the protease inhibitor nelfinavir on mitochondrially driven apoptosis.
Antiviral therapy 2005;10(8):945-51.
2005: Caceres Cesar; Gomez Enrique J; Garcia Felipe; Chausa Paloma; Guzman Jorge; Del Pozo Francisco; Gatell Jose Maria
A Home Integral Telecare System for HIV/AIDS Patients.
Studies in health technology and informatics 2005;114():23-9.
2005: Laguno Montse; Milinkovic Ana; de Lazzari Elisa; Murillas Javier; Martínez Esteban; Blanco Jose Luis; Loncá Montse; Biglia Alejandra; Leon Agathe; García Mercedes; Larrousse Maria; García Felipe; Miró Jose Maria; Gatell Jose Maria; Mallolas Josep
Incidence and risk factors for mitochondrial toxicity in treated HIV/HCV-coinfected patients.
Antiviral therapy 2005;10(3):423-9.
2005: Millán Olga; Brunet Mercè; Martorell Jaume; García Felipe; Vidal Elena; Rojo Isabel; Plana Montserrat; Gallart Teresa; Pumarola Tomas; Miró Jose M; Gatell Jose M
Pharmacokinetics and pharmacodynamics of low dose mycophenolate mofetil in HIV-infected patients treated with abacavir, efavirenz and nelfinavir.
Clinical pharmacokinetics 2005;44(5):525-38.
2005: Podzamczer Daniel; Ferrer Elena; Gatell Josep Maria; Niubo Jordi; Dalmau David; Leon Agathe; Knobel Hernando; Polo Carolina; Iniguez Daniel; Ruiz Isaac
Early virological failure with a combination of tenofovir, didanosine and efavirenz.
Antiviral therapy 2005;10(1):171-7.
2004: Badía Xavier; Podzamczer Daniel; Moral Irene; Roset Montse; Arnaiz Joan A; Loncà Montse; Casiró Arnaldo; Rosón Beatriz; Gatell Jose M;
Health-related quality of life in HIV patients switching to twice-daily indinavir/ritonavir regimen or continuing with three-times-daily indinavir-based therapy.
Antiviral therapy 2004;9(6):979-85.
2004: Laguno Montserrat; Blanch Jordi; Murillas Javier; Blanco Jose Luis; León Agothe; Lonca Montserrat; Larrousse Mario; Biglia Alejandra; Martinez Esteban; García Felipe; Miró Jose M; de Pablo Joan; Gatell Josep M; Mallolas Josep
Depressive symptoms after initiation of interferon therapy in human immunodeficiency virus-infected patients with chronic hepatitis C.
Antiviral therapy 2004;9(6):905-9.
2004: Iribarren José Antonio; Labarga Pablo; Rubio Rafael; Berenguer Juan; Miró José M; Antela Antonio; González Juan; Moreno Santiago; Arrizabalaga Julio; Chamorro Lourdes; Clotet Bonaventura; Gatell José M; López-Aldeguer José; Martínez Esteban; Polo Rosa; Tuset Montserrat; Viciana Pompeyo; Santamaría Juan Miguel; Kindelán José María; Ribera Esteve; Segura Ferrán;
[Spanish GESIDA/Nacional AIDS Plan Recommendations for antiretroviral therapy in HIV-infected Adults (October 2004)]
Enfermedades infecciosas y microbiología clínica 2004;22(10):564-642.
2004: Miró Oscar; López Sònia; Rodríguez de la Concepción Marisa; Martínez Esteban; Pedrol Enric; Garrabou Glòria; Giralt Marta; Cardellach Francesc; Gatell Josep M; Vilarroya Francesc; Casademont Jordi
Upregulatory mechanisms compensate for mitochondrial DNA depletion in asymptomatic individuals receiving stavudine plus didanosine.
Journal of acquired immune deficiency syndromes (1999) 2004;37(5):1550-5.
2004: Mocroft Amanda; Gatell Jose; Reiss Peter; Ledergerber Bruno; Kirk Ole; Vella Stefano; Blaxhult Anders; Phillips Andrew N; Lundgren Jens;
Causes of death in HIV infection: the key determinant to define the clinical response to anti-HIV therapy.
AIDS (London, England) 2004;18(17):2333-7.
2004: Biglia Alejandra; Blanco Jose L; Martínez Esteban; Domingo Pere; Casamitjana Roser; Sambeat María; Milinkovic Ana; Garcia Mercedes; Laguno Montserrat; Leon Agathe; Larrousse Maria; Lonca Montserrat; Mallolas Josep; Gatell Jose M
Gynecomastia among HIV-infected patients is associated with hypogonadism: a case-control study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(10):1514-9.
2004: Mocroft A; Monforte A d'Arminio; Kirk O; Johnson M A; Friis-Moller N; Banhegyi D; Blaxhult A; Mulcahy F; Gatell J M; Lundgren J D;
Changes in hospital admissions across Europe: 1995-2003. Results from the EuroSIDA study.
HIV medicine 2004;5(6):437-47.
2004: Martínez Esteban; Tuset Montserrat; Milinkovic Ana; Miró José M; Gatell José M
Management of dyslipidaemia in HIV-infected patients receiving antiretroviral therapy.
Antiviral therapy 2004;9(5):649-63.
2004: Jiménez-Expósito M J; Torres G; Baraldés A; Benito N; Marco F; Paré J C; Moreno A; Claramonte X; Mestres C A; Almela M; García de la María C; Pérez N; Schell W A; Corey G R; Perfect J; Jiménez de Anta M T; Gatell J M; Miró J M
Native valve endocarditis due to Candida glabrata treated without valvular replacement: a potential role for caspofungin in the induction and maintenance treatment.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(7):e70-3.
2004: Miró Oscar; López Sònia; Martínez Esteban; Pedrol Enric; Milinkovic Ana; Deig Elisabeth; Garrabou Glòria; Casademont Jordi; Gatell Josep M; Cardellach Francesc
Mitochondrial effects of HIV infection on the peripheral blood mononuclear cells of HIV-infected patients who were never treated with antiretrovirals.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(5):710-6.
2004: Laguno Montserrat; Murillas Javier; Blanco José Luis; Martínez Esteban; Miquel Rosa; Sánchez-Tapias José M; Bargallo Xavier; García-Criado Angeles; de Lazzari Elisa; Larrousse María; León Agathe; Loncá Montserrat; Milinkovic Ana; Gatell Josep M; Mallolas Josep
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patients.
AIDS (London, England) 2004;18(13):F27-36.
2004: Florence Eric; García Felipe; Plana Montserrat; Fumero Emilio; Castro Pedro; Lopez Anna; Cruceta Anna; Gil Cristina; Arnedo Mireia; Miró José M; Pumarola Tomás; Gallart Teresa; Gatell José M
Long-term clinical follow-up, without antiretroviral therapy, of patients with chronic HIV-1 infection with good virological response to structured treatment interruption.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(4):569-74.
2004: Fernandez-Cruz E; Moreno S; Navarro J; Clotet B; Bouza E; Carbone J; Peña J M; Pérez Molina J; Podzamczer D; Rubio R; Ocaña I; Pulido F; Viciana P; Maradona J A; Blazquez R; Barros C; Quereda C; Rodriguez-Sainz C; Gil J; Abad M L; Díaz L; Cantó C; Muñoz M A; Ferrer E; Jou A; Sirera G; Díaz M; Lopez F; Gatell J M; Gonzalez-Lahoz J;
Therapeutic immunization with an inactivated HIV-1 Immunogen plus antiretrovirals versus antiretroviral therapy alone in asymptomatic HIV-infected subjects.
Vaccine 2004;22(23-24):2966-73.
2004: Squires Kathleen; Lazzarin Adriano; Gatell José M; Powderly William G; Pokrovskiy Vadim; Delfraissy Jean-François; Jemsek Joseph; Rivero Antonio; Rozenbaum Willy; Schrader Shannon; Sension Michael; Vibhagool Asda; Thiry Alexandra; Giordano Michael
Comparison of once-daily atazanavir with efavirenz, each in combination with fixed-dose zidovudine and lamivudine, as initial therapy for patients infected with HIV.
Journal of acquired immune deficiency syndromes (1999) 2004;36(5):1011-9.
2004: Cahn Pedro E; Gatell José M; Squires Kathleen; Percival Lisa D; Piliero Peter J; Sanne Ian A; Shelton Sarah; Lazzarin Adriano; Odeshoo Linda; Kelleher Thomas D; Thiry Alexandra; Giordano Michael D; Schnittman Stephen M
Atazanavir--a once-daily HIV protease inhibitor that does not cause dyslipidemia in newly treated patients: results from two randomized clinical trials.
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) 2004;3(3):92-8.
2004: Yeni Patrick G; Hammer Scott M; Hirsch Martin S; Saag Michael S; Schechter Mauro; Carpenter Charles C J; Fischl Margaret A; Gatell Jose M; Gazzard Brian G; Jacobsen Donna M; Katzenstein David A; Montaner Julio S G; Richman Douglas D; Schooley Robert T; Thompson Melanie A; Vella Stefano; Volberding Paul A
Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel.
JAMA : the journal of the American Medical Association 2004;292(2):251-65.
2004: Martínez Esteban; Milinkovic Ana; de Lazzari Elisa; Ravasi Giovanni; Blanco José L; Larrousse Maria; Mallolas Josep; García Felipe; Miró José M; Gatell José M
Pancreatic toxic effects associated with co-administration of didanosine and tenofovir in HIV-infected adults.
Lancet 2004;364(9428):65-7.
2004: García Felipe; Plana Montserrat; Arnedo Mireia; Brunet Merçe; Castro Pedro; Gil Cristina; Vidal Elena; Millán Olga; López Anna; Martorell Jaume; Fumero Emilio; Miró José M; Alcamí José; Pumarola Tomás; Gallart Teresa; Gatell José M
Effect of mycophenolate mofetil on immune response and plasma and lymphatic tissue viral load during and after interruption of highly active antiretroviral therapy for patients with chronic HIV infection: a randomized pilot study.
Journal of acquired immune deficiency syndromes (1999) 2004;36(3):823-30.
2004: Plana Montserrat; Garcia Felipe; Oxenius Annette; Ortiz Gabriel M; Lopez Anna; Cruceta Anna; Mestre Gabriel; Fumero Emilio; Fagard Catherine; Sambeat Maria Antonia; Segura Ferran; Miró José M; Arnedo Mireia; Lopalcos Lucia; Pumarola Tomas; Hirschel Bernard; Phillips Rodney E; Nixon Douglas F; Gallart Teresa; Gatell Jose M
Relevance of HIV-1-specific CD4+ helper T-cell responses during structured treatment interruptions in patients with CD4+ T-cell nadir above 400/mm3.
Journal of acquired immune deficiency syndromes (1999) 2004;36(3):791-9.
2004: García Felipe; de Lazzari Elisa; Plana Montserrat; Castro Pedro; Mestre Gabriel; Nomdedeu Meritxell; Fumero Emilio; Martínez Esteban; Mallolas Josep; Blanco José L; Miró José M; Pumarola Tomás; Gallart Teresa; Gatell José M
Long-term CD4+ T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell count.
Journal of acquired immune deficiency syndromes (1999) 2004;36(2):702-13.
2004: Casado A; Badia X; Consiglio E; Ferrer E; González A; Pedrol E; Gatell J M; Azuaje C; Llibre J M; Aranda M; Barrufet P; Martínez-Lacasa J; Podzamczer D;
Health-related quality of life in HIV-infected naive patients treated with nelfinavir or nevirapine associated with ZDV/3TC (the COMBINE-QoL substudy).
HIV clinical trials 2004;5(3):132-9.
2004: Blanch Jordi; Rousaud Araceli; Martinez Esteban; De Lazzari Elisa; Milinkovic Ana; Peri Josep-Maria; Blanco José-Luis; Jaen Jesús; Navarro Victor; Massana Guillem; Gatell Josep-Maria
Factors associated with severe impact of lipodystrophy on the quality of life of patients infected with HIV-1.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;38(10):1464-70.
2004: Benito Natividad; Moreno Asunción; Filella Xavier; Miró José M; González Julià; Pumarola Tomás; Valls María Eugenia; Luna Montserrat; García Felipe; Rañó Ana; Torres Antoni; Gatell José M
Inflammatory responses in blood samples of human immunodeficiency virus-infected patients with pulmonary infections.
Clinical and diagnostic laboratory immunology 2004;11(3):608-14.
2004: Plana Montserrat; Ferrer Elena; Martínez Catalina; Podzamczer Daniel; García Felipe; Maleno María J; Barceló Juan J; García Ana; Barberá Maria J; Lacarcel Montserrat; Miró José M; Gallart Teresa; Gatell José M
Immune restoration in HIV-positive, antiretroviral-naive patients after 1 year of zidovudine/lamivudine plus nelfinavir or nevirapine.
Antiviral therapy 2004;9(2):197-204.
2004: Pulido Federico; Arribas Jose R; Miró Jose M; Costa María A; González Juan; Rubio Rafael; Peña Jose M; Torralba Miguel; Lonca Montserrat; Lorenzo Alicia; Cepeda Concepcion; Vázquez Juan J; Gatell Jose M;
Clinical, virologic, and immunologic response to efavirenz-or protease inhibitor-based highly active antiretroviral therapy in a cohort of antiretroviral-naive patients with advanced HIV infection (EfaVIP 2 study).
Journal of acquired immune deficiency syndromes (1999) 2004;35(4):343-50.
2004: Martínez Esteban; Domingo Pere; Galindo María J; Milinkovic Ana; Arroyo Juan A; Baldovi Francisco; Larrousse María; León Agathe; de Lazzari Elisa; Gatell José M
Risk of metabolic abnormalities in patients infected with HIV receiving antiretroviral therapy that contains lopinavir-ritonavir.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;38(7):1017-23.
2004: Fumero Emilio; García Felipe; Gatell J M
Immunosuppressive drugs as an adjuvant to HIV treatment.
The Journal of antimicrobial chemotherapy 2004;53(3):415-7.
2004: López Sònia; Miró Oscar; Martínez Esteban; Pedrol Enric; Rodríguez-Santiago Benjamín; Milinkovic Ana; Soler Anna; García-Viejo Miguel A; Nunes Virginia; Casademont Jordi; Gatell Josep M; Cardellach Francesc
Mitochondrial effects of antiretroviral therapies in asymptomatic patients.
Antiviral therapy 2004;9(1):47-55.
2004: Walker Ulrich A; Bäuerle Jochen; Laguno Montse; Murillas Javier; Mauss Stefan; Schmutz Günther; Setzer Bernhard; Miquel Rosa; Gatell José M; Mallolas Josep
Depletion of mitochondrial DNA in liver under antiretroviral therapy with didanosine, stavudine, or zalcitabine.
Hepatology (Baltimore, Md.) 2004;39(2):311-7.
2003: Navarrete Pilar; Morente Vanessa; García Felipe; Alós Lluçia; Arnedo Mireia; Plana Montserrat; Gil Cristina; Caballero Miguel; Miró José M; Martínez Esteban; Fumero Emilio; Castro Pedro; Blanco José L; Mallolas Josep; Blanch José L; Cruceta Anna; Mestre Gabriel; Pumarola Tomás; Gallart Teresa; Gatell José M
Predictors of tonsillar tissue HIV-1 viral burden at baseline and after 1 year of antiretroviral therapy.
Antiviral therapy 2003;8(6):635-7.
2003: Miró Oscar; López Sònia; Martínez Esteban; Rodríguez-Santiago Benjamín; Blanco José L; Milinkovic Ana; Miró Jose M; Nunes Virginia; Casademont Jordi; Gatell Josep M; Cardellach Francesc
Short communication: reversible mitochondrial respiratory chain impairment during symptomatic hyperlactatemia associated with antiretroviral therapy.
AIDS research and human retroviruses 2003;19(11):1027-32.
2003: Martínez Esteban; Domingo Pere; Ribera Esteban; Milinkovic Ana; Arroyo Juan A; Conget Ignacio; Pérez-Cuevas José B; Casamitjana Roser; de Lazzari Elisa; Bianchi Luis; Montserrat Enric; Roca Merce; Burgos Rosa; Arnaiz Juan A; Gatell José M
Effects of metformin or gemfibrozil on the lipodystrophy of HIV-infected patients receiving protease inhibitors.
Antiviral therapy 2003;8(5):403-10.
2003: Martí L; Moreno A; Filella X; Marín J L; Almela M; Benito N; Sánchez M; Gatell J M
[Cytokines value as a sepsis and mortality predictor in elderly patients with fever]
Medicina clínica 2003;121(10):361-6.
2003: Martínez Esteban; Arnaiz Juan A; Podzamczer Daniel; Dalmau David; Ribera Esteban; Domingo Pere; Knobel Hernando; Riera Melcior; Pedrol Enric; Force Lluis; Llibre Josep M; Segura Ferran; Richart Cristóbal; Cortés Cristina; Javaloyas Manuel; Aranda Miquel; Cruceta Ana; de Lazzari Elisa; Gatell José M;
Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infection.
The New England journal of medicine 2003;349(11):1036-46.
2003: Miró Oscar; López Sònia; Pedrol Enric; Rodríguez-Santiago Benjamín; Martínez Esteban; Soler Anna; Milinkovic Ana; Casademont Jordi; Nunes Virginia; Gatell Josep M; Cardellach Francesc
Mitochondrial DNA depletion and respiratory chain enzyme deficiencies are present in peripheral blood mononuclear cells of HIV-infected patients with HAART-related lipodystrophy.
Antiviral therapy 2003;8(4):333-8.
2003: Fagard Catherine; Oxenius Annette; Günthard Huldrych; Garcia Felipe; Le Braz Michelle; Mestre Gabriel; Battegay Manuel; Furrer Hansjakob; Vernazza Pietro; Bernasconi Enos; Telenti Amalio; Weber Rainer; Leduc Dominique; Yerly Sabine; Price David; Dawson Sara J; Klimkait Thomas; Perneger Thomas V; McLean Angela; Clotet Bonaventura; Gatell Jose M; Perrin Luc; Plana Montserrat; Phillips Rodney; Hirschel Bernard;
A prospective trial of structured treatment interruptions in human immunodeficiency virus infection.
Archives of internal medicine 2003;163(10):1220-6.
2003: van Leeuwen Remko; Katlama Christine; Murphy Robert L; Squires Kathleen; Gatell José; Horban Andrej; Clotet Bonaventura; Staszewski Shlomo; van Eeden Arne; Clumeck Nathan; Moroni Mauro; Pavia Andrew T; Schmidt Reinhold E; Gonzalez-Lahoz Juan; Montaner Julio; Antunes Francisco; Gulick Robert; Bánhegyi Dénes; van der Valk Marc; Reiss Peter; van Weert Liesbeth; van Leth Frank; Johnson Victoria A; Sommadossi Jean-Pierre; Lange Joep M
A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients.
AIDS (London, England) 2003;17(7):987-99.
2003: Arnaiz Juan A; Mallolas Josep; Podzamczer Daniel; Gerstoft Jan; Lundgren Jens D; Cahn Pedro; Fätkenheuer Gerd; D'Arminio-Monforte Antonella; Casiró Arnaldo; Reiss Peter; Burger David M; Stek Michael; Gatell José M;
Continued indinavir versus switching to indinavir/ritonavir in HIV-infected patients with suppressed viral load.
AIDS (London, England) 2003;17(6):831-40.
2003: Horcajada J P; Pumarola T; Martínez J A; Tapias G; Bayas J M; de la Prada M; García F; Codina C; Gatell J M; Jiménez de Anta M T
A nosocomial outbreak of influenza during a period without influenza epidemic activity.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2003;21(2):303-7.
2003: Ferrer Elena; Podzamczer Daniel; Arnedo Mireia; Fumero Emilio; McKenna Paula; Rinehart Alex; Pérez José L; Barberá María J; Pumarola Tomás; Gatell José M; Gudiol Francisco;
Genotype and phenotype at baseline and at failure in human immunodeficiency virus-infected antiretroviral-naive patients in a randomized trial comparing zidovudine and lamivudine plus nelfinavir or nevirapine.
The Journal of infectious diseases 2003;187(4):687-90.
2003: Losa J E; Miro J M; Del Rio A; Moreno-Camacho A; Garcia F; Claramonte X; Marco F; Mestres C A; Azqueta M; Gatell J M;
Infective endocarditis not related to intravenous drug abuse in HIV-1-infected patients: report of eight cases and review of the literature.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2003;9(1):45-54.
2003: García Felipe; Plana Montserrat; Arnedo Mireia; Ortiz Gabriel M; Miró José M; Lopalco Lucia; Lori Franco; Pumarola Tomás; Gallart Teresa; Gatell José M
A cytostatic drug improves control of HIV-1 replication during structured treatment interruptions: a randomized study.
AIDS (London, England) 2003;17(1):43-51.
2002: Vidal Carme; Arnedo Mireia; Garcia Felipe; Mestre Gabriel; Plana Montserrat; Cruceta Anna; Capon Alicia; Gallart Teresa; Miro José M; Pumarola Tomas; Gatell José M
Genotypic and phenotypic resistance patterns in early-stage HIV-1-infected patients failing initial therapy with stavudine, didanosine and nevirapine.
Antiviral therapy 2002;7(4):283-7.
2002: Blanch Jordi; Rousaud Araceli; Martínez Esteban; De Lazzari Elisa; Peri Josep-Maria; Milinkovic Ana; Perez-Cuevas Jose-Bernardo; Blanco José-Luís; Gatell Josep-Maria
Impact of lipodystrophy on the quality of life of HIV-1-infected patients.
Journal of acquired immune deficiency syndromes (1999) 2002;31(4):404-7.
2002: Codina Carlos; Martínez Mireia; Tuset Montserrat; del Cacho Elena; Martín María Teresa; Miró José M; Mallolas Josep; de Lazzari Elisa; García Felipe; Martínez Esteban; Gatell José M; Ribas Josep
[Comparison of three methods to calculate adherence in patients receiving antiretroviral treatment]
Enfermedades infecciosas y microbiología clínica 2002;20(10):484-90.
2002: Schacker Timothy W; Nguyen Phuong L; Martinez Esteban; Reilly Cavan; Gatell Jose M; Horban Andrzej; Bakowska Elzbieta; Berzins Baiba; van Leeuwen Remko; Wolinsky Steven; Haase Ashley T; Murphy Robert L
Persistent abnormalities in lymphoid tissues of human immunodeficiency virus-infected patients successfully treated with highly active antiretroviral therapy.
The Journal of infectious diseases 2002;186(8):1092-7.
2002: Soriano Alex; Martínez Catalina; García Felipe; Plana Montserrat; Palou Eduard; Lejeune Marylène; Aróstegui Juan I; De Lazzari Elisa; Rodriguez Carmen; Barrasa Alicia; Lorenzo José I; Alcamí José; del Romero Jorge; Miró José M; Gatell José M; Gallart Teresa
Plasma stromal cell-derived factor (SDF)-1 levels, SDF1-3'A genotype, and expression of CXCR4 on T lymphocytes: their impact on resistance to human immunodeficiency virus type 1 infection and its progression.
The Journal of infectious diseases 2002;186(7):922-31.
2002: Garcia Felipe; Plana Montserrat; Mestre Gabriel; Cruceta Anna; Martinez Esteban; Miró José M; Mallolas Josep; Tuset Montserrat; Pumorola Tomas; Gallart Teresa; Gatell José M
Metabolic and immunological effects of antiretroviral agents in healthy individuals receiving post-exposure prophylaxis.
Antiviral therapy 2002;7(3):195-7.
2002: García Felipe; Plana Montserrat; Mestre Gabriel; Arnedo Mireia; Gil Cristina; Miró José M; Cruceta Anna; Pumarola Tomas; Gallart Teresa; Gatell José M
Immunological and virological factors at baseline may predict response to structured therapy interruption in early stage chronic HIV-1 infection.
AIDS (London, England) 2002;16(13):1761-5.
2002: García Felipe; Clotet Bonaventura; Moreno Santiago; López Bernaldo De Quirós Juan Carlos; Gatell José M
[Treatment interruptions in clinical practice]
Enfermedades infecciosas y microbiologia clinica 2002;20 Suppl 2():68-73.
2002: Tortajada Cecilia; Pérez-Cuevas Bernardo; Moreno Asuncion; Martínez Esteban; Mallolas Jose; García Felipe; Valls Eugenia; Miró José M; De Lazzari Esther; Gatell José M
Highly active antiretroviral therapy (HAART) modifies the incidence and outcome of visceral leishmaniasis in HIV-infected patients.
Journal of acquired immune deficiency syndromes (1999) 2002;30(3):364-6.
2002: Arribas Jose R; Pulido Federico; Miró Jose M; Costa María A; González Juan; Rubio Rafael; Peña Jose M; Torralba Miguel; Lonca Montserrat; Lorenzo Alicia; Del Palacio Angel; Vázquez Juan José; Gatell Jose M;
High effectiveness of efavirenz-based highly active antiretroviral therapy in HIV-1-infected patients with fewer than 100 CD4 cells/microl and opportunistic diseases: the EfaVIP Study (Efavirenz in Very Immunosuppressed Patients).
AIDS (London, England) 2002;16(11):1554-6.
2002: Yeni Patrick G; Hammer Scott M; Carpenter Charles C J; Cooper David A; Fischl Margaret A; Gatell Jose M; Gazzard Brian G; Hirsch Martin S; Jacobsen Donna M; Katzenstein David A; Montaner Julio S G; Richman Douglas D; Saag Michael S; Schechter Mauro; Schooley Robert T; Thompson Melanie A; Vella Stefano; Volberding Paul A
Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel.
JAMA : the journal of the American Medical Association 2002;288(2):222-35.
2002: Martínez Esteban; Miró Jose M; Almirante Benito; Aguado Jose M; Fernandez-Viladrich Pedro; Fernandez-Guerrero Manuel L; Villanueva Jose L; Dronda Fernando; Moreno-Torrico Alfonso; Montejo Miguel; Llinares Pedro; Gatell Jose M;
Effect of penicillin resistance of Streptococcus pneumoniae on the presentation, prognosis, and treatment of pneumococcal endocarditis in adults.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;35(2):130-9.
2002: Podzamczer Daniel; Ferrer Elena; Consiglio Ezequiel; Gatell José Mariá; Perez Pepa; Perez José Luis; Luna Elena; González Alicia; Pedrol Enric; Lozano Luisa; Ocaña Imma; Llibre Josep María; Casiró Arnaldo; Aranda Miquel; Barrufet Pilar; Martínez-Lacasa Javier; Miró José María; Badía Xavier; Casado Alfonso; Lupo Sergio; Cahn Pedro; Maños Manel; Estela Jordi
A randomized clinical trial comparing nelfinavir or nevirapine associated to zidovudine/lamivudine in HIV-infected naive patients (the Combine Study).
Antiviral therapy 2002;7(2):81-90.
2002: Rubio Rafael; Berenguer Juan; Miró José M; Antela Antonio; Iribarren José Antonio; González Juan; Guerra Luis; Moreno Santiago; Arrizabalaga Julio; Clotet Buenaventura; Gatell José M; Laguna Fernando; Martínez Esteban; Parras Francisco; Santamaría Juan Miguel; Tuset Montserrat; Viciana Pompeyo
[Recommendations of the Spanish AIDS Study Group (GESIDA) and the National Aids Plan (PNS) for antiretroviral treatment in adult patients with human immunodeficiency virus infection in 2002]
Enfermedades infecciosas y microbiología clínica 2002;20(6):244-303.
2002: Sambola A; Miro J M; Tornos M P; Almirante B; Moreno-Torrico A; Gurgui M; Martinez E; Del Rio A; Azqueta M; Marco F; Gatell J M
Streptococcus agalactiae infective endocarditis: analysis of 30 cases and review of the literature, 1962-1998.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;34(12):1576-84.
2002: Plana Montserrat; Martínez Catalina; García Felipe; Maleno María J; Barceló Juan J; García Ana; Lejeune Marylène; Vidal Carmen; Cruceta Anna; Miró José M; Pumarola Tomás; Gallart Teresa; Gatell José M
Immunologic reconstitution after 1 year of highly active antiretroviral therapy, with or without protease inhibitors.
Journal of acquired immune deficiency syndromes (1999) 2002;29(5):429-34.
2002: Blanch Jordi; Rousaud Araceli; Hautzinger Martin; Martínez Esteban; Peri Josep-Maria; Andrés Susana; Cirera Esteve; Gatell Josep-Maria; Gastó Cristóbal
Assessment of the efficacy of a cognitive-behavioural group psychotherapy programme for HIV-infected patients referred to a consultation-liaison psychiatry department.
Psychotherapy and psychosomatics 2002;71(2):77-84.
2002: Lundgren Jens D; Mocroft Amanda; Gatell Jose M; Ledergerber Bruno; D'Arminio Monforte Antonella; Hermans Philippe; Goebel Frank-Detlef; Blaxhult Anders; Kirk Ole; Phillips Andrew N;
A clinically prognostic scoring system for patients receiving highly active antiretroviral therapy: results from the EuroSIDA study.
The Journal of infectious diseases 2002;185(2):178-87.
2001: Gatell J M
From amprenavir to GW433908.
Journal of HIV therapy 2001;6(4):95-9.
2001: Saras-Nacenta M; López-Púa Y; Lípez-Cortés L F; Mallolas J; Gatell J M; Carné X
Determination of efavirenz in human plasma by high-performance liquid chromatography with ultraviolet detection.
Journal of chromatography. B, Biomedical sciences and applications 2001;763(1-2):53-9.
2001: Martínez E; Arnedo M; Giner V; Gil C; Caballero M; Alós L; García F; Holtzer C; Mallolas J; Miró J M; Pumarola T; Gatell J M
Lymphoid tissue viral burden and duration of viral suppression in plasma.
AIDS (London, England) 2001;15(12):1477-82.
2001: Blanch J; Martínez E; Rousaud A; Blanco J L; García-Viejo M A; Peri J M; Mallolas J; De Lazzari E; De Pablo J; Gatell J M
Preliminary data of a prospective study on neuropsychiatric side effects after initiation of efavirenz.
Journal of acquired immune deficiency syndromes (1999) 2001;27(4):336-43.
2001: Martínez E; Blanco J L; Arnaiz J A; Pérez-Cuevas J B; Mocroft A; Cruceta A; Marcos M A; Milinkovic A; García-Viejo M A; Mallolas J; Carné X; Phillips A; Gatell J M
Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy.
AIDS (London, England) 2001;15(10):1261-8.
2001: Sarasa-Nacenta M; López-Púa Y; Mallolas J; Blanco J L; Gatell J M; Carné X
Simultaneous determination of the HIV-protease inhibitors indinavir, amprenavir, ritonavir, saquinavir and nelfinavir in human plasma by reversed-phase high-performance liquid chromatography.
Journal of chromatography. B, Biomedical sciences and applications 2001;757(2):325-32.
2001: García F; Plana M; Ortiz G M; Bonhoeffer S; Soriano A; Vidal C; Cruceta A; Arnedo M; Gil C; Pantaleo G; Pumarola T; Gallart T; Nixon D F; Miró J M; Gatell J M
The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection.
AIDS (London, England) 2001;15(9):F29-40.
2001: Benito N; Rañó A; Moreno A; González J; Luna M; Agustí C; Danés C; Pumarola T; Miró J M; Torres A; Gatell J M
Pulmonary infiltrates in HIV-infected patients in the highly active antiretroviral therapy era in Spain.
Journal of acquired immune deficiency syndromes (1999) 2001;27(1):35-43.
2001: Martinez E; Mocroft A; García-Viejo M A; Pérez-Cuevas J B; Blanco J L; Mallolas J; Bianchi L; Conget I; Blanch J; Phillips A; Gatell J M
Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study.
Lancet 2001;357(9256):592-8.
2001: Gatell J M; Blanco J L; Alcamí J; Antela A; Arrizabalaga J; Casado J L; Clotet B; Delgado R; Erice A; Guerra L; Guerrero A; Iribarren J A; Leal M; López J C; Menéndez-Arias L; Miró J M; Moreno S; Pérez J L; Pumarola T; Rubio R; Ruiz L; Santamaría J M; Soriano V; Telenti A; Viciana P
[GESIDA Consensus document on the use of resistance studies in clinical practice]
Enfermedades infecciosas y microbiología clínica 2001;19(Monografico):53-60.
2001: Alves C; Nicolás J M; Miró J M; Torres A; Agustì C; Gonzalez J; Raño A; Benito N; Moreno A; Garcìa F; Millá J; Gatell J M
Reappraisal of the aetiology and prognostic factors of severe acute respiratory failure in HIV patients.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2001;17(1):87-93.
2001: Mocroft A; Phillips A N; Miller V; Gatell J; van Lunzen J; Parkin J M; Weber R; Roge B; Lazzarin A; Lundgren J D;
The use of and response to second-line protease inhibitor regimens: results from the EuroSIDA study.
AIDS (London, England) 2001;15(2):201-9.
2001: Garcia F; Plana M; Soriano A; Vidal C; Arnedo M; Gil C; Cruceta A; Pumarola T; Gallart T; Miro J M; Gatell J M
Predictors of progression in chronically infected naive patients with plasma viraemia below 5000 copies/ml and CD4 T lymphocytes greater than 500 x 10(6)/I.
AIDS (London, England) 2001;15(1):131-3.
2001: Martínez E; Garcia-Viejo M A; Blanch L; Gatell J M
Lipodystrophy syndrome in patients with HIV infection: quality of life issues.
Drug safety : an international journal of medical toxicology and drug experience 2001;24(3):157-66.
2000: Tortajada C; Garcia F; Plana M; Gallart T; Maleno M J; Miró J M; Gatell J M
Comparison of T-cell subsets' reconstitution after 12 months of highly active antiretroviral therapy initiated during early versus advanced states of HIV disease.
Journal of acquired immune deficiency syndromes (1999) 2000;25(4):296-305.
2000: Mallolas J; Blanco J L; Sarasa M; Giner V; Martínez E; García-Viejo M A; Arnaiz J A; Cruceta A; Soy D; Tuset M; Soriano A; Codina C; Pumarola T; Carné X; Gatell J M
Dose-finding study of once-daily indinavir/ritonavir plus zidovudine and lamivudine in HIV-infected patients.
Journal of acquired immune deficiency syndromes (1999) 2000;25(3):229-35.
2000: Martínez E; García-Viejo M A; Marcos M A; Pérez-Cuevas J B; Blanco J L; Mallolas J; Miró J M; Gatell J M
Discontinuation of secondary prophylaxis for cryptococcal meningitis in HIV-infected patients responding to highly active antiretroviral therapy.
AIDS (London, England) 2000;14(16):2615-7.
2000: García F; Knobel H; Sambeat M A; Arrizabalaga J; Aranda M; Romeu J; Dalmau D; Segura F; Gomez-Sirvent J L; Ferrer E; Cruceta A; Gallart T; Pumarola T; Miró J M; Gatell J M;
Comparison of twice-daily stavudine plus once- or twice-daily didanosine and nevirapine in early stages of HIV infection: the scan study.
AIDS (London, England) 2000;14(16):2485-94.
2000: Martínez E; García-Viejo M A; Blanco J L; Bianchi L; Buira E; Conget I; Casamitjana R; Mallolas J; Gatell J M
Impact of switching from human immunodeficiency virus type 1 protease inhibitors to efavirenz in successfully treated adults with lipodystrophy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;31(5):1266-73.
2000: Miró J M; Antela A; Arrizabalaga J; Clotet B; Gatell J M; Guerra L; Antonio Iribarren J; Laguna F; Moreno S; Parras F; Rubio R; Santamaría J M; Viciana P;
[Recommendations of GESIDA (Grupo de Estudio de SIDA)/National Plan on AIDS with respect to the anti-retroviral treatment in adult patients infected with the human immunodeficiency virus in the year 2000 (II)]
Enfermedades infecciosas y microbiología clínica 2000;18(8):396-412.
2000: García F; Alonso M M; Romeu J; Knobel H; Arrizabalaga J; Ferrer E; Dalmau D; Ruiz I; Vidal F; Frances A; Segura F; Gomez-Sirvent J L; Cruceta A; Clotet B; Pumarola T; Gallart T; O'Brien W A; Miró J M; Gatell J M
Comparison of immunologic restoration and virologic response in plasma, tonsillar tissue, and cerebrospinal fluid in HIV-1-infected patients treated with double versus triple antiretroviral therapy in very early stages: The Spanish EARTH-2 Study. Early Anti-Retroviral Therapy Study.
Journal of acquired immune deficiency syndromes (1999) 2000;25(1):26-35.
2000: Plana M; García F; Gallart T; Tortajada C; Soriano A; Palou E; Maleno M J; Barceló J J; Vidal C; Cruceta A; Miró J M; Gatell J M
Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection.
AIDS (London, England) 2000;14(13):1921-33.
2000: Miró J M; Antela A; Arrizabalaga J; Clotet B; Gatell J M; Guerra L; Iribarren J A; Laguna F; Moreno S; Parras F; Rubio R; Santamaría J M; Viciana P
[Recommendation of GESIDA (AIDS Study Group)/National Plan on AIDS with respect to the anti-retroviral treatment in adult patients infected with the human immunodeficiency virus in the year 2000 (I)]
Enfermedades infecciosas y microbiología clínica 2000;18(7):329-51.
2000: Blaxhult A; Kirk O; Pedersen C; Dietrich M; Barton S E; Gatell J M; Mulcahy F; Hirschel B; Mocroft A; Lundgren J D
Regional differences in presentation of AIDS in Europe.
Epidemiology and infection 2000;125(1):143-51.
2000: Podzamczer D; Miró J M; Ferrer E; Gatell J M; Ramón J M; Ribera E; Sirera G; Cruceta A; Knobel H; Domingo P; Polo R; Leyes M; Cosin J; Fariñas M C; Arrizabalaga J; Martínez-Lacasa J; Gudiol F
Thrice-weekly sulfadiazine-pyrimethamine for maintenance therapy of toxoplasmic encephalitis in HIV-infected patients. Spanish Toxoplasmosis Study Group.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2000;19(2):89-95.
2000: García F; Vidal C; Plana M; Cruceta A; Gallart M T; Pumarola T; Miro J M; Gatell J M
Residual low-level viral replication could explain discrepancies between viral load and CD4+ cell response in human immunodeficiency virus-infected patients receiving antiretroviral therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;30(2):392-4.
2000: Carpenter C C; Cooper D A; Fischl M A; Gatell J M; Gazzard B G; Hammer S M; Hirsch M S; Jacobsen D M; Katzenstein D A; Montaner J S; Richman D D; Saag M S; Schechter M; Schooley R T; Thompson M A; Vella S; Yeni P G; Volberding P A
Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel.
JAMA : the journal of the American Medical Association 2000;283(3):381-90.
2000: Codina C; Miró J M; Tuset M; Claramonte J; Gomar C; Gotsens R; Gómez B; Suárez S; Abellana R; Ascaso C; Cartaña R; Rodríguez E; Asenjo M; Carné X; Trilla A; Marco F; Gómez J; Brunet M; Pomar J L; Gatell J M; Ribas J
[Vancomycin and teicoplanin use as antibiotic prophylaxis in cardiac surgery: pharmacoeconomic study]
Medicina clínica 2000;114 Suppl 3():54-61.
1999: Mocroft A; Madge S; Johnson A M; Lazzarin A; Clumeck N; Goebel F D; Viard J P; Gatell J; Blaxhult A; Lundgren J D
A comparison of exposure groups in the EuroSIDA study: starting highly active antiretroviral therapy (HAART), response to HAART, and survival.
Journal of acquired immune deficiency syndromes (1999) 1999;22(4):369-78.
1999: García F; Romeu J; Grau I; Sambeat M A; Dalmau D; Knobel H; Gomez-Sirvent J L; Arrizabalaga J; Cruceta A; Clotet B G; Podzamczer D; Pumarola T; Gallart T; O'Brien W A; Miró J M; Gatell J M
A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 study.
AIDS (London, England) 1999;13(17):2377-88.
1999: Martínez E; Leguizamón M; Mallolas J; Miró J M; Gatell J M
Influence of environmental temperature on incidence of indinavir-related nephrolithiasis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1999;29(2):422-5.
1999: García F; Niebla G; Romeu J; Vidal C; Plana M; Ortega M; Ruiz L; Gallart T; Clotet B; Miró J M; Pumarola T; Gatell J M
Cerebrospinal fluid HIV-1 RNA levels in asymptomatic patients with early stage chronic HIV-1 infection: support for the hypothesis of local virus replication.
AIDS (London, England) 1999;13(12):1491-6.
1999: Vidal F; Mensa J; Martínez J A; Almela M; Marco F; Gatell J M; Richart C; Soriano E; Jiménez de Anta M T
Pseudomonas aeruginosa bacteremia in patients infected with human immunodeficiency virus type 1.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1999;18(7):473-7.
1999: García F; Plana M; Vidal C; Cruceta A; O'Brien W A; Pantaleo G; Pumarola T; Gallart T; Miró J M; Gatell J M
Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy.
AIDS (London, England) 1999;13(11):F79-86.
1999: Gatell J
Coming therapies: amprenavir.
International journal of clinical practice. Supplement 1999;103():42-4.
1999: Martínez E; Conget I; Lozano L; Casamitjana R; Gatell J M
Reversion of metabolic abnormalities after switching from HIV-1 protease inhibitors to nevirapine.
AIDS (London, England) 1999;13(7):805-10.
1998: Martínez E; Gatell J; Morán Y; Aznar E; Buira E; Guelar A; Mallolas J; Soriano E
High incidence of herpes zoster in patients with AIDS soon after therapy with protease inhibitors.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998;27(6):1510-3.
1998: Moreno S; Arrizabalaga J; Gatell J M; Clotet B; Aguirrebengoa K; Antela A; Iribarren J A; Laguna F; Miró J M; Ocaña I; Rubio R; Viciana P; Podzamczer D
[Recommendations for antiretroviral treatment in 1998. AIDS Working Group of the Spanish Society for Infectious Diseases and Clinical Microbiology (SEIMC)]
Enfermedades infecciosas y microbiología clínica 1998;16(8):374-6.
1998: Ribera E; Miró J M; Cortés E; Cruceta A; Merce J; Marco F; Planes A; Paré J C; Moreno A; Ocaña I; Gatell J M; Pahissa A
Influence of human immunodeficiency virus 1 infection and degree of immunosuppression in the clinical characteristics and outcome of infective endocarditis in intravenous drug users.
Archives of internal medicine 1998;158(18):2043-50.
1998: Vidal C; García F; Gatell J M; Leal M; Clotet B; Pumarola T; Miró J M; Mallolas J; Ruiz L; Cruceta A; Tortajada C
Predictive factors influencing peak viral load drop in response to nucleoside reverse transcriptase inhibitors in antiretroviral-naive HIV-1-infected patients.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1998;19(1):55-60.
1998: Vidal C; García F; Romeu J; Ruiz L; Miró J M; Cruceta A; Soriano A; Pumarola T; Clotet B; Gatell J M
Lack of evidence of a stable viral load set-point in early stage asymptomatic patients with chronic HIV-1 infection.
AIDS (London, England) 1998;12(11):1285-9.
1998: Moreno S; Arrizabalaga J; Gatell J M; Clotet B; Aguirrebengoa K; Antela A; Iribarren J A; Laguna F; Miró J M; Ocaña I; Rubio R; Viciana P; Podzamczer D
[Recommendations on antiretroviral treatment. The AIDS Study Group of the Spanish Society of Infectious Diseases and Clinical Microbiology]
Medicina clínica 1998;110(3):109-16.
1998: Miró J M; Arrizabalaga J; Gatell J M
[GESIDA survey on antiretroviral treatment in 1998. Working Group for the Study of AIDS (GESIDA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)]
Enfermedades infecciosas y microbiología clínica 1998;16 Suppl 1():69-70.
1997: Mallolas J; Arrizabalaga J; Loncá M; Gatell J M; Adán A; Martínez-Chamorro E; Tortajada C; Rodríguez-Arrondo F; Blanco A; Guelar A; Soriano E
Cytomegalovirus disease in HIV-1-infected patients treated with protease inhibitors.
AIDS (London, England) 1997;11(14):1785-7.
1997: Muñoz-Rodríguez F J; Padró S; Pastor P; Rosa-Re D; Valls M E; Miró J M; Gatell J M
Pleural and peritoneal leishmaniasis in an AIDS patient.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1997;16(3):246-8.
1997: Mallolas J; Gatell J M; Gómez-Sirvent J L; Buira E; Zamora L; Alecrim-Andrade J; Adán A; Morales M; Miró J M; Lonca M; Guelar A; Soriano E
[Prophylaxis secondary to retinitis by CMV in patients with AIDS: the efficacy of an intermittent schedule of 3 days/week]
Enfermedades infecciosas y microbiología clínica 1997;15(2):61-4.
1997: García F; Vidal C; Gatell J M; Miró J M; Soriano A; Pumarola T
Viral load in asymptomatic patients with CD4+ lymphocyte counts above 500 x 10(6)/l.
AIDS (London, England) 1997;11(1):53-7.
1996: Sala R; Miró J M; Feliu E; Bianchi J L; Gatell J M; Reverter J C; Soriano E; García San Miguel J
[In vitro effect of heroin on neutrophil polymorphonuclear leukocytes from peripheral blood]
Medicina clínica 1996;107(19):726-9.
1996: Vidal F; Mensa J; Almela M; Martínez J A; Marco F; Casals C; Gatell J M; Soriano E; Jimenez de Anta M T
Epidemiology and outcome of Pseudomonas aeruginosa bacteremia, with special emphasis on the influence of antibiotic treatment. Analysis of 189 episodes.
Archives of internal medicine 1996;156(18):2121-6.
1996: Gatell J M; González-Lahoz J; Clotet B; Antunes F; Kasparova L; Gil-Aguado A; Saballs P; Santamaria J M; Podzamczer D; Miro J M; Jou A; Verdejo J; Doroana M; Thomis J
Switching from zidovudine to didanosine in patients with symptomatic HIV infection and disease progression. ddI Iberian Study Group.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1996;12(3):249-58.
1996: Zamora L; Mallolas J; Gatell J M
Prophylaxis of pneumocystis pneumonia and toxoplasmosis.
Annals of internal medicine 1996;124(12):1096.
1996: Buira E; Gatell J M; Zamora L; Mallolas J; Miró J M; Soriano E
[Analysis of 1,187 consecutive cases of AIDS: variations and trends in time]
Enfermedades infecciosas y microbiología clínica 1996;14(5):290-5.
1996: Gatell J M; Leal M; Mallolas J; Vidal C; Pumarola T; Parra R; Padró S; Caruz A; Falgueras T; Rey C; Sánchez-Quijano A; Torres Y; Lissen E; Jiménez de Anta M T; Soriano E
A pilot case-control study of zidovudine compared with zidovudine plus didanosine in patients with advanced HIV-1 disease and no previous experience with antiretrovirals.
Antiviral therapy 1996;1(2):105-12.
1995: Podzamczer D; Miró J M; Bolao F; Gatell J M; Cosín J; Sirera G; Domingo P; Laguna F; Santamaría J; Verdejo J
Twice-weekly maintenance therapy with sulfadiazine-pyrimethamine to prevent recurrent toxoplasmic encephalitis in patients with AIDS. Spanish Toxoplasmosis Study Group.
Annals of internal medicine 1995;123(3):175-80.
1995: Trilla A; Codina C; Salles M; Gatell J M; Zaragoza M; Marco F; Navasa M; Mulet J; Ribas J; Jimenez de Anta M T
A cluster of fever and hypotension on a surgical intensive care unit related to the contamination of plasma expanders by cell wall products of Bacillus stearothermophilus.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 1995;16(6):335-9.
1995: Fernandez P; Torres A; Miro J M; Vieigas C; Mallolas J; Zamora L; Gatell J M; Valls M E; Riquelme R; Rodríguez-Roisin R
Prognostic factors influencing the outcome in pneumocystis carinii pneumonia in patients with AIDS.
Thorax 1995;50(6):668-71.
1995: Miró O; Moreno A; Valls M E; Miró J M; Piqué J M; Bordas J M; Moreno-Martínez A; Bombí J A; Gatell J M
[Intestinal microsporidiosis in patients with AIDS: study of 3 cases]
Medicina clínica 1995;104(3):96-9.
1994: Galofré J; Moreno A; Mensa J; Miró J M; Gatell J M; Almela M; Claramonte X; Lozano L; Trilla A; Mallolas J
Analysis of factors influencing the outcome and development of septic metastasis or relapse in Salmonella bacteremia.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1994;18(6):873-8.
1994: Miró J M; Buira E; Mallolas J; Gallart T; Moreno A; Zamora L; Vilella R; Gatell J M; Soriano E
[CD4+ lymphocytes and opportunistic infections and neoplasms in patients with human immunodeficiency virus infection]
Medicina clínica 1994;102(15):566-70.
1994: Guelar A; Miró J M; Mallolas J; Zamora L; Cardenal C; Gatell J M; Soriano E
[Therapeutic alternatives for cases of cerebral toxoplasmosis in patients with AIDS: clarithromycin and atovaquone]
Enfermedades infecciosas y microbiología clínica 1994;12(3):137-40.
1994: Moreno A; Gatell J M; Mensa J; Valls M E; Vila J; Claramonte X; Miró J M; Mallolas J; Zamora L; Lozano L
[Incidence of enteropathogens in patients with human immunodeficiency virus infection]
Medicina clínica 1994;102(6):205-8.
1994: Sans M; Gatell J M; Rafel M; Mallolas J; Soriano E
[Varicella pneumonia in adults infected by HIV-1. Presentation of 2 cases]
Enfermedades infecciosas y microbiología clínica 1994;12(1):26-30.
1993: Guelar A; Gatell J M; Verdejo J; Podzamczer D; Lozano L; Aznar E; Miró J M; Mallolas J; Zamora L; González J
A prospective study of the risk of tuberculosis among HIV-infected patients.
AIDS (London, England) 1993;7(10):1345-9.
1993: Gatell J M
[HIV infection. When will the cure be found?]
Medicina clínica 1993;100 Suppl 1():35-6.
1993: Montón C; Mallolas J; Miró J M; Alsina M; Gatell J M; Soriano E
[Epidemic Kaposi's sarcoma in women: presentation of 4 cases]
Medicina clínica 1993;100(5):179-80.
1993: Mallolas J; Zamora L; Gatell J M; Miró J M; Vernet E; Valls M E; Soriano E; SanMiguel J G
Primary prophylaxis for Pneumocystis carinii pneumonia: a randomized trial comparing cotrimoxazole, aerosolized pentamidine and dapsone plus pyrimethamine.
AIDS (London, England) 1993;7(1):59-64.
1992: Bisbe J; Miro J M; Latorre X; Moreno A; Mallolas J; Gatell J M; de la Bellacasa J P; Soriano E
Disseminated candidiasis in addicts who use brown heroin: report of 83 cases and review.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1992;15(6):910-23.
1992: Zamora L; Gatell J M; Barrera J M; Ercilla G; Gil C; Buira E; Miro J M; Soriano E
Influence on survival of p24 antigen levels in patients with AIDS or advanced AIDS related complex treated with zidovudine.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1992;11(12):1181-5.
1992: Pedrol E; Mallolas J; González-Clemente J M; Miró J M; Azón A; Gatell J M; Moreno A; Mensa J; Soriano E
[Cryptococcosis: presentation of 26 cases]
Medicina clínica 1992;98(10):361-5.
1992: Buira E; Gatell J M; Miró J M; Batalla J; Zamora L; Mallolas J; Aznar E; Soriano E; San Miguel J G
Influence of treatment with zidovudine (ZDV) on the long-term survival of AIDS patients.
Journal of acquired immune deficiency syndromes 1992;5(7):737-42.
1991: Brancós M A; Peris P; Miró J M; Monegal A; Gatell J M; Mallolas J; Mensa J; García S; Muñoz-Gomez J
Septic arthritis in heroin addicts.
Seminars in arthritis and rheumatism 1991;21(2):81-7.
1991: Garcia S; Lozano M L; Gatell J M; Soriano E; Ramon R; Sanmiguel J G
Prophylaxis against infection. Single-dose cefonicid compared with multiple-dose cefamandole.
The Journal of bone and joint surgery. American volume 1991;73(7):1044-8.
1991: Mallolas J; Zamora L; Gatell J M; Miró J M; Soriano E
Low-dose co-trimoxazole, aerosolised pentamidine, or dapsone plus pyrimethamine for prevention of Pneumocystis carinii pneumonia.
Lancet 1991;337(8750):1162-3.
1991: Trilla A; Gatell J M; Mensa J; Latorre X; Almela M; Soriano E; Jimenez de Anta M T; Garcia San Miguel J
Risk factors for nosocomial bacteremia in a large Spanish teaching hospital: a case-control study.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 1991;12(3):150-6.
1991: Mallolas J; Gatell J M; Miró J M; Marco F; Bisbe J; Jiménez de Anta M T; Soriano E
Analysis of prognostic factors in 274 consecutive episodes of Pseudomonas aeruginosa bacteremia.
Antibiotics and chemotherapy 1991;44():106-14.
1991: Aznar R; Mateu M; Miró J M; Gatell J M; Gimferrer J M; Aznar E; Mallolas J; Soriano E; Sanchez-Lloret J
Antibiotic prophylaxis in non-cardiac thoracic surgery: cefazolin versus placebo.
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 1991;5(10):515-8.
1990: Mallolas J; Valls M E; Miró J M; Gatell J M; Xaubet A; Picado C; Jiménez de Anta M T; Soriano E
[Diagnosis of pneumonia caused by Pneumocystis carinii using induced sputum]
Enfermedades infecciosas y microbiología clínica 1990;8(8):511-3.
1990: González-Clemente J M; Miró J M; Pedrol E; Alvarez R; Gatell J M; Mallolas J; Graus F; Mercader J M; Guelar A; Jiménez de Anta M T
[Encephalic toxoplasmosis in patients with the acquired immunodeficiency syndrome. A clinico-radiological study and the therapeutic results in 78 cases]
Medicina clínica 1990;95(12):441-6.
1990: Pedrol E; González-Clemente J M; Gatell J M; Mallolas J; Miró J M; Graus F; Alvarez R; Mercader J M; Berenguer J; Jiménez de Anta M T
Central nervous system toxoplasmosis in AIDS patients: efficacy of an intermittent maintenance therapy.
AIDS (London, England) 1990;4(6):511-7.
1990: Félez M A; Miró J M; Mallolas J; Valls M E; Moreno A; Gatell J M; Soriano E
[Enteritis caused by Isospora belli in patients with the acquired immunodeficiency syndrome. Description of 9 cases]
Medicina clínica 1990;95(3):84-8.
1990: Gatell J M; Miró J M
[The acquired immunodeficiency syndrome after 10 years]
Medicina clínica 1990;94(11):420-2.
1990: Podzamczer D; Gudiol F; Bolao F; Gatell J M; Clotet B; Miró J M
[Treatment of the most common infections in patients with human immunodeficiency virus infection. Task-force on AIDS of the Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica]
Enfermedades infecciosas y microbiología clínica 1990;8(3):161-75.
1989: Mallolas J; Azón A; Miró J M; Castel T; Gatell J M
Epidemic Kaposi's sarcoma in Spanish AIDS patients.
AIDS (London, England) 1989;3(12):857.
1989: Rello J; Gatell J M; Almirall J; Campistol J M; Gonzalez J; Puig de la Bellacasa J
Evaluation of culture techniques for identification of catheter-related infection in hemodialysis patients.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1989;8(7):620-2.
1989: Gatell J M; Podzamczer D; Clotet B; Estany C; Miro J M
Natural history of HIV infection in European drug users.
AIDS (London, England) 1989;3(6):404.
1989: Almirall J; Gonzalez J; Rello J; Campistol J M; Montoliu J; Puig de la Bellacasa J; Revert L; Gatell J M
Infection of hemodialysis catheters: incidence and mechanisms.
American journal of nephrology 1989;9(6):454-9.
1988: Mallolas J; Latorre X; Gatell J M; Miró J M; Francés A; Mariscal D; Soriano E
[Clinical analysis of the first consecutive 145 cases of acquired immunodeficiency syndrome]
Medicina clínica 1988;91(19):721-4.
1988: Soriano E; Mallolas J; Gatell J M; Latorre X; Miró J M; Pecchiar M; Mensa J; Trilla A; Moreno A
Characteristics of tuberculosis in HIV-infected patients: a case-control study.
AIDS (London, England) 1988;2(6):429-32.
1988: Bisbe J; Gatell J M; Puig J; Mallolas J; Martinez J A; Jimenez de Anta M T; Soriano E
Pseudomonas aeruginosa bacteremia: univariate and multivariate analyses of factors influencing the prognosis in 133 episodes.
Reviews of infectious diseases 1988;10(3):629-35.
1988: Mallolas J; Gatell J M; Rovira M; Conget J I; Trilla A; Soriano E
Vertebral arch tuberculosis in two human immunodeficiency virus-seropositive heroin addicts.
Archives of internal medicine 1988;148(5):1125-7.
1988: Hernández E; Puyuelo T; Gatell J M; Barrera J M; Pumarola T
[Occupational risk of infection by human immunodeficiency virus]
Medicina clínica 1988;90(19):767-8.
1988: Gatell J M; Trilla A; Latorre X; Almela M; Mensa J; Moreno A; Miro J M; Martinez J A; Jimenez de Anta M T; Soriano E
Nosocomial bacteremia in a large Spanish teaching hospital: analysis of factors influencing prognosis.
Reviews of infectious diseases 1988;10(1):203-10.
1988: Trilla A; Martos J A; Gatell J M; Latorre X
[Meningoencephalitis and mononucleosis syndrome associated with acute infection by human immunodeficiency virus]
Medicina clínica 1988;90(1):42-3.
1987: Miró J M; Puig de la Bellacasa J; Odds F C; Gill B K; Bisbe J; Gatell J M; Gonzalez J; Latorre X; Jimenez de Anta M T; Soriano E
Systemic candidiasis in Spanish heroin addicts: a possible source of infection.
The Journal of infectious diseases 1987;156(5):857-8.
1987: Gatell J M; Garcia S; Lozano L; Soriano E; Ramon R; SanMiguel J G
Perioperative cefamandole prophylaxis against infections.
The Journal of bone and joint surgery. American volume 1987;69(8):1189-93.
1987: Gatell J M; Ferran F; Araujo V; Bonet M; Soriano E; Traserra J; SanMiguel J G
Univariate and multivariate analyses of risk factors predisposing to auditory toxicity in patients receiving aminoglycosides.
Antimicrobial agents and chemotherapy 1987;31(9):1383-7.
1987: Rello J; Gatell J M; Almela M; Jiménez de Anta M J; Andreu J; Soriano E; García San Miguel J
[Septicemia caused by Listeria monocytogenes in the adult]
Medicina clínica 1987;88(14):537-40.
1986: Gatell J M; Rello J; Miro J M; Martinez J A; Soriano E; SanMiguel Garcia J
Cloxacillin-induced neutropenia.
The Journal of infectious diseases 1986;154(2):372.
1986: Brancós M A; Gatell J M; Guañabens N; Miró J M; Romaní M; Ramón R; Rotés-Querol J; García San Miguel J
[Prospective study of septic arthritis in a general hospital. Comparison of different risk groups and evaluation of a pre-established medico-surgical therapeutic protocol]
Medicina clínica 1986;87(2):45-8.
1986: Latorre X; Gatell J M; Pumarola T; Miró J M; Laborí C; Pifarré M; Vidal J; Jiménez de Anta M T; Soriano E; Pumarola A
[Prevalence of antibodies against HTLV-III/LAV in subpopulations at risk of suffering the acquired immune deficiency syndrome]
Medicina clínica 1986;86(3):113-4.
1986: Latorre X; Cuturi C; Miro J M; Anegon I; Gatell J M; Gallart T; Bruguera M; Pumarola T; Trilla A; Ginel J
Lymphocyte subpopulations in Spanish parenteral drug addicts.
Scandinavian journal of infectious diseases 1986;18(1):71-8.
1985: Gatell J M; SanMiguel J G; Zamora L; Araujo V; Castells C; Moreno A; Jimenez de Anta M T; Marin J L; Elena M; Ballesta A
Tobramycin and amikacin nephrotoxicity. Value of serum creatinine versus urinary concentration of beta-2-microglobulin.
Nephron 1985;41(4):337-43.
1984: Gatell J M; SanMiguel J G; Araujo V; Zamora L; Maña J; Ferrer M; Bonet M; Bohe M; Jimenez de Anta M T
Prospective randomized double-blind comparison of nephrotoxicity and auditory toxicity of tobramycin and netilmicin.
Antimicrobial agents and chemotherapy 1984;26(5):766-9.
1984: Miró J M; Puig de la Bellacasa J; Gatell J M; Ginel A; Jiménez de Anta M T; Pumarola A; García San Miguel J
[Rate of mucosocutaneous carriers of staphylococci in heroin addicts of the Barcelona area and the microbiological characteristics of heroin and the material of injection]
Medicina clínica 1984;83(15):620-3.
1984: Gatell J M; Riba J; Lozano M L; Maña J; Ramon R; García SanMiguel J
Prophylactic cefamandole in orthopaedic surgery.
The Journal of bone and joint surgery. American volume 1984;66(8):1219-22.
1983: Miró J M; Brancós M A; Gatell J M; García San Miguel J
[Additional data on septic osteoarthritis in drug addicts]
Medicina clínica 1983;81(16):738.
1983: Gatell J M; San Miguel J G; Zamora L; Araujo V; Bonet M; Bohé M; Jimenez de Anta M T; Farré M; Elena M; Ballesta A; Marin J L
Comparison of the nephrotoxicity and auditory toxicity of tobramycin and amikacin.
Antimicrobial agents and chemotherapy 1983;23(6):897-901.
1982: Martinez-Vea A; Gatell J M; Segura F; Heiman C; Elena M; Ballesta A M; Mundo M R
Diagnostic value of tumoral markers in serous effusions: carcinoembryonic antigen, alpha1-acidglycoprotein, alpha-fetoprotein, phosphohexose isomerase, and beta 2-microglobulin.
Cancer 1982;50(9):1783-8.
1981: Segura F; Zamora L; Sasal M; Mensa J; Gatell J M; Soriano E; García San Miguel J
[Fever of unknown origin: true dimensions of the diagnostic problem (author's transl)]
Medicina clínica 1981;77(4):150-2.
1981: Gatell J M; Miro J M; Sasal M; Ferrer O; Rodriguez M; Garcia San Miguel J
Legionella pneumophila antigen in brain.
Lancet 1981;2(8239):202-3.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

José Gatell

Research Profile (preview)

Disorders

Living Beings

Procedures

Concepts & Ideas

Chemicals & Drugs

Geographic Areas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of José Gatell (preview)

All Publications